<SEC-DOCUMENT>0000950103-26-010267.txt : 20260706
<SEC-HEADER>0000950103-26-010267.hdr.sgml : 20260706
<ACCEPTANCE-DATETIME>20260706165909
ACCESSION NUMBER:		0000950103-26-010267
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20260706
DATE AS OF CHANGE:		20260706

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIGROUP INC
		CENTRAL INDEX KEY:			0000831001
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				521568099
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-293732
		FILM NUMBER:		261156714

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		2125591000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS GROUP INC
		DATE OF NAME CHANGE:	19950519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS INC
		DATE OF NAME CHANGE:	19940103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMERICA CORP /NEW/
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citigroup Global Markets Holdings Inc.
		CENTRAL INDEX KEY:			0000200245
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				112418067
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-293732-02
		FILM NUMBER:		261156715

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-816-6000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CITIGROUP GLOBAL MARKETS HOLDINGS INC
		DATE OF NAME CHANGE:	20030404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON SMITH BARNEY HOLDINGS INC
		DATE OF NAME CHANGE:	19971128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp249757_424b2-us26n4897.htm
<DESCRIPTION>PRELIMINARY PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">
    <P STYLE="color: red; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">The information in this preliminary
    pricing supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities
    and Exchange Commission. This preliminary pricing supplement and the accompanying product supplement, underlying supplement, prospectus
    supplement and prospectus are not an offer to sell these securities, nor are they soliciting an offer to buy these securities, in any
    state where the offer or sale is not permitted.</P>
    <P STYLE="color: red; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="color: red; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">SUBJECT TO COMPLETION, DATED JULY
6, 2026</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 53%; font-size: 10pt; color: #888888"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD>
    <TD STYLE="width: 47%">
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">July&nbsp;&nbsp;&nbsp;&nbsp;
, 2026</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Medium-Term Senior Notes,
Series N</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Pricing Supplement No. 2026-USNCH32955</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Filed Pursuant to Rule 424(b)(2)</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Registration Statement Nos.
333-293732 and 333-293732-02</P></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; color: rgb(34,146,208); margin: 0pt 0">Market-Linked Securities Linked to the Worst Performing
of the EURO STOXX 50<SUP>&reg;</SUP> Index and the iShares<SUP>&reg;</SUP> MSCI EAFE ETF Due July 12, 2029</P>

<P STYLE="color: #2292D0; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 9.15pt"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>The securities offered by this pricing supplement are unsecured debt securities issued by Citigroup Global Markets Holdings Inc. and
guaranteed by Citigroup Inc. Unlike conventional debt securities, the securities do not pay interest. Instead, the securities offer the
potential for a return at maturity based on the performance of the worst performing of the underlyings specified below from its initial
underlying value to its final underlying value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 9.15pt"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>If the worst performing underlying appreciates from its initial underlying value to its final underlying value, you will receive a
positive return at maturity equal to that appreciation <I>multiplied</I> by the upside participation rate, subject to the maximum return
at maturity specified below. However, if the worst performing underlying remains the same or depreciates from its initial underlying value
to its final underlying value, you will be repaid the stated principal amount of your securities at maturity but will not receive any
return on your investment. Even if the worst performing underlying appreciates from its initial underlying value to its final underlying
value, so that you do receive a positive return at maturity, there is no assurance that your total return at maturity on the securities
will compensate you for the effects of inflation or be as great as the yield you could have achieved on a conventional debt security of
ours of comparable maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 9.15pt"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>In exchange for the possibility of a positive return at maturity based on the performance of the underlying and repayment of the principal
amount even if the worst performing underlying depreciates, investors in the securities must be willing to forgo (i) any return on the
securities in excess of the maximum return at maturity and (ii) dividends with respect to any underlying. <B>If the worst performing underlying
does not appreciate from its initial underlying value to its final underlying value, you will not receive any return on your investment
in the securities.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 9.15pt"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>You will be subject to risks associated with each of the underlyings and will be negatively affected by adverse movements in any one
of the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 9.15pt"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>In order to obtain the modified exposure to the worst performing underlying that the securities provide, investors must be willing
to accept (i) an investment that may have limited or no liquidity and (ii) the risk of not receiving any amount due under the securities
if we and Citigroup Inc. default on our obligations. <B>All payments on the securities are subject to the credit risk of Citigroup Global
Markets Holdings Inc. and Citigroup Inc.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #2292D0">
    <TD COLSPAN="7"><FONT STYLE="color: white"><B>KEY TERMS</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Issuer:</B></FONT></TD>
    <TD COLSPAN="6"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Holdings Inc., a wholly owned subsidiary of Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Guarantee:</B></FONT></TD>
    <TD COLSPAN="6"><FONT STYLE="font-size: 10pt">All payments due on the securities are fully and unconditionally guaranteed by Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD ROWSPAN="3" STYLE="background-color: White"><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Underlyings:</B></FONT></TD>
    <TD STYLE="background-color: White; border-right: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="background-color: White; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Underlying</FONT></TD>
    <TD COLSPAN="2" STYLE="background-color: White; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Initial underlying value</FONT><SUP>*</SUP></TD>
    <TD STYLE="background-color: White">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="border-right: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">EURO STOXX 50<SUP>&reg;</SUP> Index</FONT></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="border-right: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">iShares<SUP>&reg;</SUP> MSCI EAFE ETF</FONT></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD COLSPAN="6"><SUP>*</SUP><FONT STYLE="font-size: 10pt">For each underlying, its closing value on the pricing date</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Stated principal amount:</B></FONT></TD>
    <TD COLSPAN="6"><FONT STYLE="font-size: 10pt">$1,000 per security</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Pricing date:</B></FONT></TD>
    <TD COLSPAN="6"><FONT STYLE="font-size: 10pt">July 9, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Issue date:</B></FONT></TD>
    <TD COLSPAN="6"><FONT STYLE="font-size: 10pt">July 14, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Valuation date:</B></FONT></TD>
    <TD COLSPAN="6"><FONT STYLE="font-size: 10pt">July 9, 2029, subject to postponement if such date is not a scheduled trading day or certain market disruption events occur</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Maturity date:</B></FONT></TD>
    <TD COLSPAN="6"><FONT STYLE="font-size: 10pt">July 12, 2029</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Payment at maturity:</B></FONT></TD>
    <TD COLSPAN="6"><FONT STYLE="font-size: 10pt">You will receive at maturity for each security you then hold, the stated principal amount <I>plus</I> the return amount, which will be either zero or positive</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Return amount:</B></FONT></TD>
    <TD COLSPAN="6">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the final underlying value of the worst performing underlying on
    the valuation date is <B>greater than</B> its initial underlying value:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt">$1,000 &times; the underlying return of the worst performing
    underlying &times; the upside participation rate, subject to the maximum return at maturity</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the final underlying value of the worst performing underlying on
    the valuation date is <B>less than or equal to</B> its initial underlying value:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt">$0</P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Final underlying value:</B></FONT></TD>
    <TD COLSPAN="6"><FONT STYLE="font-size: 10pt">For each underlying, its closing value on the valuation date</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Upside participation rate:</B></FONT></TD>
    <TD COLSPAN="6"><FONT STYLE="font-size: 10pt">100.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Worst performing underlying:</B></FONT></TD>
    <TD COLSPAN="6"><FONT STYLE="font-size: 10pt">The underlying with the lowest underlying return</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Underlying return:</B></FONT></TD>
    <TD COLSPAN="6"><FONT STYLE="font-size: 10pt">For each underlying, (i) its final underlying value <I>minus</I> its initial underlying value, <I>divided by</I> (ii) its initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Maximum return at maturity:</B></FONT></TD>
    <TD COLSPAN="6"><FONT STYLE="font-size: 10pt">$530.00 per security (53.00% of the stated principal amount). The payment at maturity per security will not exceed the stated principal amount plus the maximum return at maturity.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Listing:</B></FONT></TD>
    <TD COLSPAN="6"><FONT STYLE="font-size: 10pt">The securities will not be listed on any securities exchange</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Paying agent:</B></FONT></TD>
    <TD COLSPAN="6"><FONT STYLE="font-size: 10pt">Citibank, N.A.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD COLSPAN="6"><FONT STYLE="font-size: 10pt">17333XBQ1 / US17333XBQ16</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Underwriter:</B></FONT></TD>
    <TD COLSPAN="6"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Inc. (&ldquo;<B>CGMI</B>&rdquo;), an affiliate of the issuer, acting as principal</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Underwriting fee and issue price:</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Issue price<SUP>(1)</SUP></B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Underwriting fee<SUP>(2)</SUP></B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Proceeds to issuer</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Per security:</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #2292D0"><B>Total:</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$</FONT></TD></TR>
  <TR>
    <TD STYLE="width: 24%">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 12%">&nbsp;</TD>
    <TD STYLE="width: 12%">&nbsp;</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">(1) Citigroup Global Markets Holdings
Inc. currently expects that the estimated value of the securities on the pricing date will be at least $915.50 per security, which will
be less than the issue price. The estimated value of the securities is based on CGMI&rsquo;s proprietary pricing models and our internal
funding rate. It is not an indication of actual profit to CGMI or other of our affiliates, nor is it an indication of the price, if any,
at which CGMI or any other person may be willing to buy the securities from you at any time after issuance. See &ldquo;Valuation of the
Securities&rdquo; in this pricing supplement.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">(2) CGMI will pay selected dealers a structuring
fee of up to $5.00 for each security sold in this offering. We may also engage other firms to provide marketing or promotional services
in connection with the distribution of the securities. CGMI will pay these service providers a fee of up to $5.00 per security in consideration
for providing marketing, education, structuring or referral services with respect to financial advisors or selected dealers. For more
information on the distribution of the securities, see &ldquo;Supplemental Plan of Distribution&rdquo; in this pricing supplement. CGMI
and its affiliates may profit from expected hedging activity related to this offering, even if the value of the securities declines.
See &ldquo;Use of Proceeds and Hedging&rdquo; in the accompanying prospectus.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">In addition, CGMI
will pay to one or more electronic platform providers a fee of up to $1.50 for each security sold in this offering where related selected
dealers and/or custodians implement or utilize such providers.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investing in the securities involves risks not associated with an
investment in conventional debt securities. See &ldquo;Summary Risk Factors&rdquo; beginning on page PS-6.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of the securities or determined that this pricing supplement and the accompanying
product supplement, underlying supplement, prospectus supplement and prospectus are truthful or complete. Any representation to the contrary
is a criminal offense.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>You should read this pricing supplement together
with the accompanying product supplement, underlying supplement, prospectus supplement and prospectus, which can be accessed via the hyperlinks
below:</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010326002643/dp241932_424b2-pp0311.htm" STYLE="color: rgb(34,146,208)"><FONT STYLE="color: #2292D0"><B>Product Supplement No. EA-03-11 dated February 25, 2026</B></FONT></A>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010326002640/dp241935_424b2-us13.htm" STYLE="color: rgb(34,146,208)"><FONT STYLE="color: #2292D0"><B>Underlying Supplement No. 13 dated February 25, 2026</B></FONT></A><BR>
<A HREF="https://www.sec.gov/Archives/edgar/data/200245/000119312526071985/d53413d424b2.htm" STYLE="color: rgb(34,146,208)"><FONT STYLE="color: rgb(34,146,208)"><B>Prospectus Supplement and Prospectus each dated February 25, 2026</B></FONT></A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The securities are not bank deposits and are
not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of,
or guaranteed by, a bank.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-bottom: #2292D0 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">Additional Information</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>General.</B> The terms of the securities are set forth in the accompanying
product supplement, prospectus supplement and prospectus, as supplemented by this pricing supplement. The accompanying product supplement,
prospectus supplement and prospectus contain important disclosures that are not repeated in this pricing supplement. For example, the
accompanying product supplement contains important information about how the closing value of each underlying will be determined and about
adjustments that may be made to the terms of the securities upon the occurrence of market disruption events and other specified events
with respect to each underlying. The accompanying underlying supplement contains information about each underlying that is not repeated
in this pricing supplement. It is important that you read the accompanying product supplement, underlying supplement, prospectus supplement
and prospectus together with this pricing supplement before deciding whether to invest in the securities. Certain terms used but not defined
in this pricing supplement are defined in the accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Closing Value.</B> The &ldquo;closing value&rdquo; of an underlying
on any date is (i) in the case of an underlying that is an underlying index, its closing level on such date and (ii) in the case of an
underlying that is an underlying ETF, the closing price of its underlying shares on such date, as provided in the accompanying product
supplement. The &ldquo;underlying shares&rdquo; of an underlying ETF are its shares that are traded on a U.S. national securities exchange.
Please see the accompanying product supplement for more information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #2292D0">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #2292D0">PS<FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #2292D0 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">Payout Diagram</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The diagram below illustrates your payment at maturity for a range of
hypothetical underlying returns of the worst performing underlying.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investors in the securities will not receive any dividends with respect
to the underlyings. The diagram and examples below do not show any effect of lost dividend yield over the term of the securities.</B>
See &ldquo;Summary Risk Factors&mdash;You will not receive dividends or have any other rights with respect to the underlyings&rdquo; below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="3" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD COLSPAN="2" STYLE="border: #2292D0 1pt solid; text-align: center"><FONT STYLE="color: #2292D0"><B>Payout Diagram</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-right: #2292D0 1pt solid; border-left: #2292D0 1pt solid; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 294px; width: 398px"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%; border-left: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: right"><FONT STYLE="font-family: Wingdings; color: #2292D0">n</FONT> The Securities&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 55%; border-bottom: #2292D0 1pt solid; border-right: #2292D0 1pt solid; text-align: left"><FONT STYLE="font-family: Wingdings">n</FONT> The Worst Performing Underlying</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #2292D0">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #2292D0">PS<FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #2292D0 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">Hypothetical Examples</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below illustrate how to determine the payment at maturity
on the securities, assuming the various hypothetical final underlying values indicated below. The examples are solely for illustrative
purposes, do not show all possible outcomes and are not a prediction of what the actual payment at maturity on the securities will be.
The actual payment at maturity will depend on the actual final underlying value of the worst performing underlying.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below are based on the following hypothetical values and
do not reflect the actual initial underlying values of the underlyings. For the actual initial underlying value of each underlying, see
the cover page of this pricing supplement. We have used these hypothetical values, rather than the actual values, to simplify the calculations
and aid understanding of how the securities work. However, you should understand that the actual payment at maturity on the securities
will be calculated based on the actual initial underlying value of each underlying, and not the hypothetical values indicated below. For
ease of analysis, figures below have been rounded.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 80%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 50%; border: #2292D0 1pt solid; text-align: center"><FONT STYLE="color: #2292D0"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 50%; border-top: #2292D0 1pt solid; border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center"><FONT STYLE="color: #2292D0"><B>Hypothetical initial underlying value</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; border-left: #2292D0 1pt solid; text-align: center">EURO STOXX 50<SUP>&reg;</SUP> Index</TD>
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center">100.00</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; border-left: #2292D0 1pt solid; text-align: center">iShares<SUP>&reg;</SUP> MSCI EAFE ETF</TD>
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center">$100.00</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 1&mdash;Upside Scenario A.</B> The final underlying value
of the worst performing underlying is 105.00, resulting in a 5.00% underlying return for the worst performing underlying. In this example,
the final underlying value of the worst performing underlying is <B>greater than</B> its initial underlying value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 90%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 34%; border: #2292D0 1pt solid; text-align: center"><FONT STYLE="color: #2292D0"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: #2292D0 1pt solid; border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center"><FONT STYLE="color: #2292D0"><B>Hypothetical final underlying value</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: #2292D0 1pt solid; border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center"><FONT STYLE="color: #2292D0"><B>Hypothetical underlying return</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; border-left: #2292D0 1pt solid; text-align: center">EURO STOXX 50<SUP>&reg;</SUP> Index*</TD>
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center">105.00</TD>
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center">5.00%</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; border-left: #2292D0 1pt solid; text-align: center">iShares<SUP>&reg;</SUP> MSCI EAFE ETF</TD>
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center">$140.00</TD>
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center">40.00%</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* Worst performing underlying</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity per security = $1,000 + the return amount</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + ($1,000 &times; the underlying return of the worst performing
underlying &times; the upside participation rate), subject to the maximum return at maturity</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + ($1,000 &times; 5.00% &times; 100.00%), subject to the maximum
return at maturity</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + $50.00, subject to the maximum return at maturity</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,050.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, the worst performing underlying has appreciated from
its initial underlying value to its final underlying value, and the underlying return of the worst performing underlying <I>multiplied
by</I> the upside participation rate is less than the maximum return at maturity. As a result, your total return at maturity would equal
the underlying return of the worst performing underlying <I>multiplied by</I> the upside participation rate.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 2&mdash;Upside Scenario B.</B> The final underlying value
of the worst performing underlying is 260.00, resulting in a 160.00% underlying return for the worst performing underlying. In this example,
the final underlying value of the worst performing underlying is <B>greater than</B> its initial underlying value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 90%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 34%; border: #2292D0 1pt solid; text-align: center"><FONT STYLE="color: #2292D0"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: #2292D0 1pt solid; border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center"><FONT STYLE="color: #2292D0"><B>Hypothetical final underlying value</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: #2292D0 1pt solid; border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center"><FONT STYLE="color: #2292D0"><B>Hypothetical underlying return</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; border-left: #2292D0 1pt solid; text-align: center">EURO STOXX 50<SUP>&reg;</SUP> Index</TD>
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center">270.00</TD>
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center">170.00%</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; border-left: #2292D0 1pt solid; text-align: center">iShares<SUP>&reg;</SUP> MSCI EAFE ETF*</TD>
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center">$260.00</TD>
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center">160.00%</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* Worst performing underlying</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity per security = $1,000 + the return amount</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + ($1,000 &times; the underlying return of the worst performing
underlying &times; the upside participation rate), subject to the maximum return at maturity</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + ($1,000 &times; 160.00% &times; 100.00%), subject to the
maximum return at maturity</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + $1,600.00, subject to the maximum return at maturity</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,530.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, the worst performing underlying has appreciated from
its initial underlying value to its final underlying value, but the underlying return of the worst performing underlying <I>multiplied
by</I> the upside participation rate would exceed the maximum return at maturity. As a result, your total return at maturity in this scenario
would be limited to the maximum return at maturity, and an investment in the securities would underperform a hypothetical alternative
investment providing 1-to-1 exposure to the appreciation of the worst performing underlying without a maximum return.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #2292D0">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #2292D0">PS<FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #2292D0 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 3&mdash;Par Scenario.</B> The final underlying value of the
worst performing underlying is 95.00, resulting in a -5.00% underlying return for the worst performing underlying. In this example, the
final underlying value of the worst performing underlying is <B>less than</B> its initial underlying value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 90%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 34%; border: #2292D0 1pt solid; text-align: center"><FONT STYLE="color: #2292D0"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: #2292D0 1pt solid; border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center"><FONT STYLE="color: #2292D0"><B>Hypothetical final underlying value</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: #2292D0 1pt solid; border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center"><FONT STYLE="color: #2292D0"><B>Hypothetical underlying return</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; border-left: #2292D0 1pt solid; text-align: center">EURO STOXX 50<SUP>&reg;</SUP> Index*</TD>
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center">95.00</TD>
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center">-5.00%</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; border-left: #2292D0 1pt solid; text-align: center">iShares<SUP>&reg;</SUP> MSCI EAFE ETF</TD>
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center">$105.00</TD>
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; text-align: center">5.00%</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* Worst performing underlying</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity per security = $1,000 + the return amount</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + $0</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, the worst performing underlying has depreciated from
its initial underlying value to its final underlying value. As a result, the payment at maturity per security would equal the $1,000 stated
principal amount per security and you would not receive any positive return on your investment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #2292D0">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #2292D0">PS<FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #2292D0 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">Summary Risk Factors</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">An investment in the securities is significantly riskier than an investment
in conventional debt securities. The securities are subject to all of the risks associated with an investment in our conventional debt
securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our obligations under the securities,
and are also subject to risks associated with each underlying. Accordingly, the securities are suitable only for investors who are capable
of understanding the complexities and risks of the securities. You should consult your own financial, tax and legal advisors as to the
risks of an investment in the securities and the suitability of the securities in light of your particular circumstances.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following is a summary of certain key risk factors for investors
in the securities. You should read this summary together with the more detailed description of risks relating to an investment in the
securities contained in the section &ldquo;Risk Factors Relating to the Notes&rdquo; beginning on page EA-6 in the accompanying product
supplement. You should also carefully read the risk factors included in the accompanying prospectus supplement and in the documents incorporated
by reference in the accompanying prospectus, including Citigroup Inc.&rsquo;s most recent Annual Report on Form 10-K and any subsequent
Quarterly Reports on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Citigroup Inc. will release quarterly earnings on July 14, 2026, which
is after the pricing date but on the issue date of these securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You may not receive any return on your investment in the securities.</B> You will receive a positive return on your investment
in the securities only if the worst performing underlying appreciates from its initial underlying value to its final underlying value.
If the final underlying value of the worst performing underlying is less than or equal to its initial underlying value, you will receive
only the stated principal amount of $1,000 for each security you hold at maturity. As the securities do not pay any interest, even if
the worst performing underlying appreciates from its initial underlying value to its final underlying value, there is no assurance that
your total return at maturity on the securities will be as great as could have been achieved on our conventional debt securities of comparable
maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Although the securities provide for the repayment of the stated principal amount at maturity, you may nevertheless suffer a loss
on your investment in real value terms if the worst performing underlying declines or does not appreciate from its initial underlying
value to its final underlying value.</B> This is because inflation may cause the real value of the stated principal amount to be less
at maturity than it is at the time you invest, and because an investment in the securities represents a forgone opportunity to invest
in an alternative asset that does generate a positive real return. This potential loss in real value terms is significant given the term
of the securities. You should carefully consider whether an investment that may not provide for any return on your investment, or may
provide a return that is lower than the return on alternative investments, is appropriate for you.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Your potential return on the securities is limited.</B> Your potential total return on the securities at maturity is limited to
the maximum return at maturity, even if the worst performing underlying appreciates by significantly more than the maximum return at maturity.
If the worst performing underlying appreciates by more than the maximum return at maturity, the securities will underperform an alternative
investment providing 1-to-1 exposure to the performance of the worst performing underlying. When lost dividends are taken into account,
the securities may underperform an alternative investment providing 1-to-1 exposure to the performance of the worst performing underlying
even if the worst performing underlying appreciates by less than the maximum return at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities do not pay interest.</B> Unlike conventional debt securities, the securities do not pay interest or any other amounts
prior to maturity. You should not invest in the securities if you seek current income during the term of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to heightened risk because they have multiple underlyings.</B> The securities are more risky than similar
investments that may be available with only one underlying. With multiple underlyings, there is a greater chance that any one underlying
will perform poorly, adversely affecting your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to the risks of each of the underlyings and will be negatively affected if any one underlying performs
poorly.</B> You are subject to risks associated with each of the underlyings. If any one underlying performs poorly, you will be negatively
affected. The securities are not linked to a basket composed of the underlyings, where the blended performance of the underlyings would
be better than the performance of the worst performing underlying alone. Instead, you are subject to the full risks of whichever of the
underlyings is the worst performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You will not benefit in any way from the performance of any better performing underlying.</B> The return on the securities depends
solely on the performance of the worst performing underlying, and you will not benefit in any way from the performance of any better performing
underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You will be subject to risks relating to the relationship between the underlyings.</B> It is preferable from your perspective for
the underlyings to be correlated with each other, in the sense that their closing values tend to increase or decrease at similar times
and by similar magnitudes. By investing in the securities, you assume the risk that the underlyings will not exhibit this relationship.
The less correlated the underlyings, the more likely it is that any one of the underlyings will perform poorly over the term of the securities.
All that is necessary for the securities to perform poorly is for one of the underlyings to perform poorly. It is impossible to predict
what the relationship between the underlyings will be over the term of the securities. The underlyings differ in significant ways and,
therefore, may not be correlated with each other.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You will not receive dividends or have any other rights with respect to the underlyings.</B> You will not receive any dividends
with respect to the underlyings. This lost dividend yield may be significant over the term of the securities. The payment scenarios described
in this pricing supplement do not show any effect of such lost dividend yield over the term of the securities. In addition, you will not
have voting rights or any other rights with respect to the underlyings or the stocks included in the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Your payment at maturity depends on the closing value of the worst performing underlying on a single day.</B> Because your payment
at maturity depends on the closing value of the worst performing underlying solely on the valuation date, you are subject to the</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #2292D0">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #2292D0">PS<FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #2292D0 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">risk that the closing value of the worst
performing underlying on that day may be lower, and possibly significantly lower, than on one or more other dates during the term of the
securities. If you had invested in another instrument linked to the worst performing underlying that you could sell for full value at
a time selected by you, or if the payment at maturity were based on an average of closing values of the worst performing underlying, you
might have achieved better returns.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.</B> If we default on
our obligations under the securities and Citigroup Inc. defaults on its guarantee obligations, you may not receive anything owed to you
under the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.</B> The securities
will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the securities. CGMI currently
intends to make a secondary market in relation to the securities and to provide an indicative bid price for the securities on a daily
basis. Any indicative bid price for the securities provided by CGMI will be determined in CGMI&rsquo;s sole discretion, taking into account
prevailing market conditions and other relevant factors, and will not be a representation by CGMI that the securities can be sold at that
price, or at all. CGMI may suspend or terminate making a market and providing indicative bid prices without notice, at any time and for
any reason. If CGMI suspends or terminates making a market, there may be no secondary market at all for the securities because it is likely
that CGMI will be the only broker-dealer that is willing to buy your securities prior to maturity. Accordingly, an investor must be prepared
to hold the securities until maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Sale of the securities prior to maturity may result in a loss of principal.</B> You will be entitled to receive at least the full
stated principal amount of your securities, subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc., only
if you hold the securities to maturity. The value of the securities may fluctuate during the term of the securities, and if you are able
to sell your securities prior to maturity, you may receive less than the full stated principal amount of your securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities on the pricing date, based on CGMI&rsquo;s proprietary pricing models and our internal funding
rate, will be less than the issue price.</B> The difference is attributable to certain costs associated with selling, structuring and
hedging the securities that are included in the issue price. These costs include (i) any selling concessions or other fees paid in connection
with the offering of the securities, (ii) hedging and other costs incurred by us and our affiliates in connection with the offering of
the securities and (iii) the expected profit (which may be more or less than actual profit) to CGMI or other of our affiliates in connection
with hedging our obligations under the securities. These costs adversely affect the economic terms of the securities because, if they
were lower, the economic terms of the securities would be more favorable to you. The economic terms of the securities are also likely
to be adversely affected by the use of our internal funding rate, rather than our secondary market rate, to price the securities. See
&ldquo;The estimated value of the securities would be lower if it were calculated based on our secondary market rate&rdquo; below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities was determined for us by our affiliate using proprietary pricing models.</B> CGMI derived
the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models. In doing so, it may have
made discretionary judgments about the inputs to its models, such as the volatility of, and correlation between, the closing values of
the underlyings, dividend yields on the underlyings and interest rates. CGMI&rsquo;s views on these inputs may differ from your or others&rsquo;
views, and as an underwriter in this offering, CGMI&rsquo;s interests may conflict with yours. Both the models and the inputs to the models
may prove to be wrong and therefore not an accurate reflection of the value of the securities. Moreover, the estimated value of the securities
set forth on the cover page of this pricing supplement may differ from the value that we or our affiliates may determine for the securities
for other purposes, including for accounting purposes. You should not invest in the securities because of the estimated value of the securities.
Instead, you should be willing to hold the securities to maturity irrespective of the initial estimated value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities would be lower if it were calculated based on our secondary market rate.</B> The estimated
value of the securities included in this pricing supplement is calculated based on our internal funding rate, which is the rate at which
we are willing to borrow funds through the issuance of the securities. Our internal funding rate is generally lower than our secondary
market rate, which is the rate that CGMI will use in determining the value of the securities for purposes of any purchases of the securities
from you in the secondary market. If the estimated value included in this pricing supplement were based on our secondary market rate,
rather than our internal funding rate, it would likely be lower. We determine our internal funding rate based on factors such as the costs
associated with the securities, which are generally higher than the costs associated with conventional debt securities, and our liquidity
needs and preferences. Our internal funding rate is not an interest rate that is payable on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Because there is not an active market for traded instruments
referencing our outstanding debt obligations, CGMI determines our secondary market rate based on the market price of traded instruments
referencing the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the securities, but subject
to adjustments that CGMI makes in its sole discretion. As a result, our secondary market rate is not a market-determined measure of our
creditworthiness, but rather reflects the market&rsquo;s perception of our parent company&rsquo;s creditworthiness as adjusted for discretionary
factors such as CGMI&rsquo;s preferences with respect to purchasing the securities prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities is not an indication of the price, if any, at which CGMI or any other person may be willing
to buy the securities from you in the secondary market.</B> Any such secondary market price will fluctuate over the term of the securities
based on the market and other factors described in the next risk factor. Moreover, unlike the estimated value included in this pricing
supplement, any value of the securities determined for purposes of a secondary market transaction will be based on our secondary market
rate, which will likely result in a lower value for the securities than if our internal funding rate were used. In addition, any secondary
market price for the securities will be reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount
of the securities to be purchased in the secondary market transaction, and the expected cost of unwinding related hedging transactions.
As a result, it is likely that any secondary market price for the securities will be less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #2292D0">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #2292D0">PS<FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #2292D0 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The value of the securities prior to maturity will fluctuate based on many unpredictable factors.</B> The value of your securities
prior to maturity will fluctuate based on the closing values of the underlyings, the volatility of, and correlation between, the closing
values of the underlyings, dividend yields on the underlyings, interest rates generally, the time remaining to maturity and our and Citigroup
Inc.&rsquo;s creditworthiness, as reflected in our secondary market rate, among other factors described under &ldquo;Risk Factors Relating
to the Notes&mdash;Risk Factors Relating to All Notes&mdash;The value of your notes prior to maturity will fluctuate based on many unpredictable
factors&rdquo; in the accompanying product supplement. Changes in the closing values of the underlyings may not result in a comparable
change in the value of your securities. You should understand that the value of your securities at any time prior to maturity may be significantly
less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Immediately following issuance, any secondary market bid price provided by CGMI, and the value that will be indicated on any brokerage
account statements prepared by CGMI or its affiliates, will reflect a temporary upward adjustment.</B> The amount of this temporary upward
adjustment will steadily decline to zero over the temporary adjustment period. See &ldquo;Valuation of the Securities&rdquo; in this pricing
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The EURO STOXX 50<SUP>&reg;</SUP> Index and the iShares<SUP>&reg;</SUP> MSCI EAFE ETF are subject to risks associated with non-U.S.
markets.</B> Investments linked to the value of non-U.S. stocks involve risks associated with the securities markets in those countries,
including risks of volatility in those markets, governmental intervention in those markets and cross-shareholdings in companies in certain
countries. Also, there is generally less publicly available information about companies in some of these jurisdictions than about U.S.
companies that are subject to the reporting requirements of the SEC. Further, non-U.S. companies are generally subject to accounting,
auditing and financial reporting standards and requirements and securities trading rules that are different from those applicable to U.S.
reporting companies. The prices of securities in foreign markets may be affected by political, economic, financial and social factors
in those countries, or global regions, including changes in government, economic and fiscal policies and currency exchange laws. Moreover,
the economies in such countries may differ favorably or unfavorably from the economy of the United States in such respects as growth of
gross national product, rate of inflation, capital reinvestment, resources and self-sufficiency. In addition, the EURO STOXX 50<SUP>&reg;</SUP>
Index and the iShares<SUP>&reg;</SUP> MSCI EAFE ETF may include companies in countries with emerging markets. Countries with emerging
markets may have relatively unstable governments, may present the risks of nationalization of businesses, restrictions on foreign ownership
and prohibitions on the repatriation of assets, and may have less protection of property rights than more developed countries. The economies
of countries with emerging markets may be based on only a few industries, may be highly vulnerable to changes in local or global trade
conditions (due to economic dependence upon commodity prices and international trade), and may suffer from extreme and volatile debt burdens,
currency devaluations or inflation rates. Local securities markets may trade a small number of securities and may be unable to respond
effectively to increases in trading volume, potentially making prompt liquidation of holdings difficult or impossible at times.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Fluctuations in exchange rates will affect the closing value of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF.</B> Because the iShares<SUP>&reg;</SUP>
MSCI EAFE ETF includes stocks that trade outside the United States and the closing value of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF
is based on the U.S. dollar value of those stocks, the iShares<SUP>&reg;</SUP> MSCI EAFE ETF is subject to currency exchange rate risk
with respect to each of the currencies in which such stocks trade. Exchange rate movements may be volatile and may be driven by numerous
factors specific to the relevant countries, including the supply of, and the demand for, the applicable currencies, as well as government
policy and intervention and macroeconomic factors. Exchange rate movements may also be influenced significantly by speculative trading.
In general, if the U.S. dollar strengthens against the currencies in which the stocks included in the iShares<SUP>&reg;</SUP> MSCI EAFE
ETF trade, the closing value of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF will be adversely affected for that reason alone.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The performance of the EURO STOXX 50<SUP>&reg;</SUP> Index will not be adjusted for changes in the exchange rate between the euro
and the U.S. dollar.</B> The closing value of the EURO STOXX 50<SUP>&reg;</SUP> Index is calculated in euro, the value of which may be
subject to a high degree of fluctuation relative to the U.S. dollar. However, the performance of the EURO STOXX 50<SUP>&reg;</SUP> Index
and the value of your securities will not be adjusted for exchange rate fluctuations. If the euro appreciates relative to the U.S. dollar
over the term of the securities, the performance of the EURO STOXX 50<SUP>&reg;</SUP> Index as measured for purposes of the securities
will be less than it would have been if it offered exposure to that appreciation in addition to the change in the prices of the stocks
included in the EURO STOXX 50<SUP>&reg;</SUP> Index.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Our offering of the securities is not a recommendation of any underlying.</B> The fact that we are offering the securities does
not mean that we believe that investing in an instrument linked to the underlyings is likely to achieve favorable returns. In fact, as
we are part of a global financial institution, our affiliates may have positions (including short positions) in the underlyings or in
instruments related to the underlyings, and may publish research or express opinions, that in each case are inconsistent with an investment
linked to the underlyings. These and other activities of our affiliates may affect the closing values of the underlyings in a way that
negatively affects the value of and your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The closing value of an underlying may be adversely affected by our or our affiliates&rsquo; hedging and other trading activities.</B>
We expect to hedge our obligations under the securities through CGMI or other of our affiliates, who may take positions in the underlyings
or in financial instruments related to the underlyings and may adjust such positions during the term of the securities. Our affiliates
also take positions in the underlyings or in financial instruments related to the underlyings on a regular basis (taking long or short
positions or both), for their accounts, for other accounts under their management or to facilitate transactions on behalf of customers.
These activities could affect the closing values of the underlyings in a way that negatively affects the value of and your return on the
securities. They could also result in substantial returns for us or our affiliates while the value of the securities declines.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>We and our affiliates may have economic interests that are adverse to yours as a result of our affiliates&rsquo; business activities.</B>
Our affiliates engage in business activities with a wide range of companies. These activities include extending loans, making and facilitating
investments, underwriting securities offerings and providing advisory services. These activities could involve or affect the underlyings
in a way that negatively affects the value of and your return on the securities. They could also result in substantial returns for us
or our</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #2292D0">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #2292D0">PS<FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #2292D0 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">affiliates while the value of the securities
declines. In addition, in the course of this business, we or our affiliates may acquire non-public information, which will not be disclosed
to you.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The calculation agent, which is an affiliate of ours, will make important determinations with respect to the securities.</B> If
certain events occur during the term of the securities, such as market disruption events and other events with respect to an underlying,
CGMI, as calculation agent, will be required to make discretionary judgments that could significantly affect your return on the securities.
In making these judgments, the calculation agent&rsquo;s interests as an affiliate of ours could be adverse to your interests as a holder
of the securities. See &ldquo;Risk Factors Relating to the Notes&mdash;Risk Factors Relating to All Notes&mdash;The calculation agent,
which is an affiliate of ours, will make important determinations with respect to the notes&rdquo; in the accompanying product supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>In the case of an underlying that is an underlying ETF, even if the underlying pays a dividend that it identifies as special or
extraordinary, no adjustment will be required under the securities for that dividend unless it meets the criteria specified in the accompanying
product supplement.</B> In general, an adjustment will not be made under the terms of the securities for any cash dividend paid by the
underlying unless the amount of the dividend per share, together with any other dividends paid in the same quarter, exceeds the dividend
paid per share in the most recent quarter by an amount equal to at least 10% of the closing value of that underlying on the date of declaration
of the dividend. Any dividend will reduce the closing value of the underlying by the amount of the dividend per share. If the underlying
pays any dividend for which an adjustment is not made under the terms of the securities, holders of the securities will be adversely affected.
See &ldquo;Description of the Securities&mdash;Certain Additional Terms for Securities Linked to an Underlying Company or an Underlying
ETF&mdash;Dilution and Reorganization Adjustments&mdash;Certain Extraordinary Cash Dividends&rdquo; in the accompanying product supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>In the case of an underlying that is an underlying ETF, the securities will not be adjusted for all events that may have a dilutive
effect on or otherwise adversely affect the closing value of the underlying.</B> For example, we will not make any adjustment for ordinary
dividends or extraordinary dividends that do not meet the criteria described above, partial tender offers or additional underlying share
issuances. Moreover, the adjustments we do make may not fully offset the dilutive or adverse effect of the particular event. Investors
in the securities may be adversely affected by such an event in a circumstance in which a direct holder of the underlying shares of the
underlying would not.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>In the case of an underlying that is an underlying ETF, the securities may become linked to an underlying other than the original
underlying upon the occurrence of a reorganization event or upon the delisting of the underlying shares of that original underlying.</B>
For example, if the underlying enters into a merger agreement that provides for holders of its underlying shares to receive shares of
another entity and such shares are marketable securities, the closing value of that underlying following consummation of the merger will
be based on the value of such other shares. Additionally, if the underlying shares of the underlying are delisted, the calculation agent
may select a successor underlying. See &ldquo;Description of the Securities&mdash;Certain Additional Terms for Securities Linked to an
Underlying Company or an Underlying ETF&rdquo; in the accompanying product supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>In the case of the underlying that is an underlying ETF, the value and performance of the underlying shares of the underlying may
not completely track the performance of the underlying index that the underlying seeks to track or the net asset value per share of the
underlying.</B> In the case of the underlying that is an underlying ETF, the underlying does not fully replicate the underlying index
that it seeks to track and may hold securities different from those included in its underlying index. In addition, the performance of
the underlying will reflect additional transaction costs and fees that are not included in the calculation of its underlying index. All
of these factors may lead to a lack of correlation between the performance of the underlying and its underlying index. In addition, corporate
actions with respect to the equity securities held by the underlying (such as mergers and spin-offs) may impact the variance between the
performance of the underlying and its underlying index. Finally, because the underlying shares are traded on an exchange and are subject
to market supply and investor demand, the closing value of the underlying may differ from the net asset value per share of the underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">During periods of market volatility, securities included in
the underlying&rsquo;s underlying index may be unavailable in the secondary market, market participants may be unable to calculate accurately
the net asset value per share of the underlying and the liquidity of the underlying may be adversely affected. This kind of market volatility
may also disrupt the ability of market participants to create and redeem shares of the underlying. Further, market volatility may adversely
affect, sometimes materially, the price at which market participants are willing to buy and sell the underlying shares. As a result, under
these circumstances, the closing value of the underlying may vary substantially from the net asset value per share of the underlying.
For all of the foregoing reasons, the performance of the underlying may not correlate with the performance of its underlying index and/or
its net asset value per share, which could materially and adversely affect the value of the securities and/or reduce your return on the
securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Changes that affect the underlyings may affect the value of your securities.</B> The sponsors of the underlyings may at any time
make methodological changes or other changes in the manner in which they operate that could affect the values of the underlyings. We are
not affiliated with any such underlying sponsor and, accordingly, we have no control over any changes any such sponsor may make. Such
changes could adversely affect the performance of the underlyings and the value of and your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #2292D0">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #2292D0">PS<FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #2292D0 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">Information About the EURO STOXX 50<SUP>&reg;</SUP>
Index</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The EURO STOXX 50<SUP>&reg;</SUP> Index is composed of 50 component
stocks of market sector leaders from within the EURO STOXX<SUP>&reg;</SUP> Supersector indices, which represent the Eurozone portion of
the STOXX Europe 600<SUP>&reg;</SUP> Supersector indices. The STOXX Europe 600<SUP>&reg;</SUP> Supersector indices contain the 600 largest
stocks traded on the major exchanges of certain European countries. The EURO STOXX 50<SUP>&reg;</SUP> Index is calculated and maintained
by STOXX Limited.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please refer to the section &ldquo;Equity Index Descriptions&mdash;
The STOXX Benchmark Indices&rdquo; in the accompanying underlying supplement for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have derived all information regarding the EURO STOXX 50<SUP>&reg;</SUP>
Index from publicly available information and have not independently verified any information regarding the EURO STOXX 50<SUP>&reg;</SUP>
Index. This pricing supplement relates only to the securities and not to the EURO STOXX 50<SUP>&reg;</SUP> Index. We make no representation
as to the performance of the EURO STOXX 50<SUP>&reg;</SUP> Index over the term of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities represent obligations of Citigroup Global Markets Holdings
Inc. (guaranteed by Citigroup Inc.) only. The sponsor of the EURO STOXX 50<SUP>&reg;</SUP> Index is not involved in any way in this offering
and has no obligation relating to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">Historical Information</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of the EURO STOXX 50<SUP>&reg;</SUP> Index on July
1, 2026 was 6,282.50.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the closing value of the EURO STOXX 50<SUP>&reg;</SUP>
Index for each day such value was available from January 4, 2016 to July 1, 2026. We obtained the closing values from Bloomberg L.P.,
without independent verification. You should not take historical closing values as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="width: 100%; border: #2292D0 1pt solid; text-align: center"><FONT STYLE="color: #2292D0"><B>EURO STOXX 50<SUP>&reg;</SUP> Index &ndash; Historical Closing Values</B></FONT><B><FONT STYLE="color: white"><BR>
</FONT><FONT STYLE="color: #2292D0">January 4, 2016 to July 1, 2026</FONT></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; border-left: #2292D0 1pt solid; text-align: center"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 315px; width: 577px"></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #2292D0">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #2292D0">PS<FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #2292D0 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">Information About the iShares<SUP>&reg;</SUP> MSCI EAFE
ETF</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The iShares<SUP>&reg;</SUP> MSCI EAFE ETF is an exchange-traded fund
that seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of publicly
traded securities in certain developed markets, excluding the United States and Canada, as measured by the MSCI EAFE<SUP>&reg;</SUP> Index.
However, for purposes of the securities, the performance of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF will reflect only its price performance,
as any dividends paid on the shares of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF will not be factored into a determination of the closing
price of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF. The MSCI EAFE<SUP>&reg;</SUP> Index was developed by MSCI Inc. as an equity benchmark
for international stock performance, and is designed to measure equity market performance in certain developed markets, excluding the
United States and Canada. The iShares<SUP>&reg;</SUP> MSCI EAFE ETF is an investment portfolio managed by iShares<SUP>&reg;</SUP> Trust.
BlackRock Fund Advisors is the investment adviser to the iShares<SUP>&reg;</SUP> MSCI EAFE ETF. iShares<SUP>&reg;</SUP> Trust is a registered
investment company that consists of numerous separate investment portfolios, including the iShares<SUP>&reg;</SUP> MSCI EAFE ETF.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Information provided to or filed with the SEC by iShares<SUP>&reg;</SUP>
Trust pursuant to the Securities Act of 1933, as amended, and the Investment Company Act of 1940, as amended, can be located by reference
to SEC file numbers 333-92935 and 811-09729, respectively, through the SEC&rsquo;s website at http://www.sec.gov. In addition, information
may be obtained from other sources including, but not limited to, press releases, newspaper articles and other publicly disseminated documents.
The underlying shares of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF trade on the NYSE Arca under the ticker symbol &ldquo;EFA.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please refer to the section &ldquo;Fund Descriptions&mdash; The iShares<SUP>&reg;</SUP>
ETFs&rdquo; in the accompanying underlying supplement for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have derived all information regarding the iShares<SUP>&reg;</SUP>
MSCI EAFE ETF from publicly available information and have not independently verified any information regarding the iShares<SUP>&reg;</SUP>
MSCI EAFE ETF. This pricing supplement relates only to the securities and not to the iShares<SUP>&reg;</SUP> MSCI EAFE ETF. We make no
representation as to the performance of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF over the term of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities represent obligations of Citigroup Global Markets Holdings
Inc. (guaranteed by Citigroup Inc.) only. The sponsor of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF is not involved in any way in this
offering and has no obligation relating to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">Historical Information</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF on July
1, 2026 was $103.02.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the closing value of the iShares<SUP>&reg;</SUP>
MSCI EAFE ETF for each day such value was available from January 4, 2016 to July 1, 2026. We obtained the closing values from Bloomberg
L.P., without independent verification. You should not take historical closing values as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="width: 100%; border: #2292D0 1pt solid; text-align: center"><FONT STYLE="color: #2292D0"><B>iShares<SUP>&reg;</SUP> MSCI EAFE ETF &ndash; Historical Closing Values</B></FONT><B><FONT STYLE="color: white"><BR>
</FONT><FONT STYLE="color: #2292D0">January 4, 2016 to July 1, 2026</FONT></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #2292D0 1pt solid; border-bottom: #2292D0 1pt solid; border-left: #2292D0 1pt solid; text-align: center"><IMG SRC="image_003.jpg" ALT="" STYLE="height: 315px; width: 577px"></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #2292D0">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #2292D0">PS<FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #2292D0 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">United States Federal Income Tax Considerations</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of our counsel, Davis Polk &amp; Wardwell LLP, which
is based on current market conditions, the securities should be treated as &ldquo;contingent payment debt instruments&rdquo; for U.S.
federal income tax purposes, as described in the section of the accompanying product supplement called &ldquo;United States Federal Tax
Considerations&mdash;Tax Consequences to U.S. Holders&mdash;Notes Treated as Contingent Payment Debt Instruments,&rdquo; and the remaining
discussion is based on this treatment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If you are a U.S. Holder (as defined in the accompanying product supplement),
you will be required to recognize interest income during the term of the securities at the &ldquo;comparable yield,&rdquo; which generally
is the yield at which we could issue a fixed-rate debt instrument with terms similar to those of the securities, including the level of
subordination, term, timing of payments and general market conditions, but excluding any adjustments for the riskiness of the contingencies
or the liquidity of the securities. We are required to construct a &ldquo;projected payment schedule&rdquo; in respect of the securities
representing a payment the amount and timing of which would produce a yield to maturity on the securities equal to the comparable yield.
Assuming you hold the securities until their maturity, the amount of interest you include in income based on the comparable yield in the
taxable year in which the securities mature will be adjusted upward or downward to reflect the difference, if any, between the actual
and projected payment on the securities at maturity as determined under the projected payment schedule.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Upon the sale, exchange or retirement of the securities prior to maturity,
you generally will recognize gain or loss equal to the difference between the proceeds received and your adjusted tax basis in the securities.
Your adjusted tax basis will equal your purchase price for the securities, increased by interest previously included in income on the
securities. Any gain generally will be treated as ordinary income, and any loss generally will be treated as ordinary loss to the extent
of prior interest inclusions on the security and as capital loss thereafter.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have determined that the comparable yield for a security is a rate
of&nbsp;&nbsp;&nbsp;&nbsp;%, compounded semi-annually, and that the projected payment schedule with respect to a security consists of
a single payment of $&nbsp;&nbsp;&nbsp;&nbsp;at maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Neither the comparable yield nor the projected payment schedule constitutes
a representation by us regarding the actual amount that we will pay on the securities.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Non-U.S. Holders.</B> Subject to the discussions below regarding
Section 871(m) and in &ldquo;United States Federal Tax Considerations&mdash;Tax Consequences to Non-U.S. Holders&rdquo; and &ldquo;&mdash;FATCA&rdquo;
in the accompanying product supplement, if you are a Non-U.S. Holder (as defined in the accompanying product supplement) of the securities,
under current law you generally will not be subject to U.S. federal withholding or income tax in respect of any payment on or any amount
received on the sale, exchange or retirement of the securities, provided that (i) income in respect of the securities is not effectively
connected with your conduct of a trade or business in the United States, and (ii) you comply with the applicable certification requirements.
See &ldquo;United States Federal Tax Considerations&mdash;Tax Consequences to Non-U.S. Holders&rdquo; in the accompanying product supplement
for a more detailed discussion of the rules applicable to Non-U.S. Holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As discussed under &ldquo;United States Federal Tax Considerations&mdash;Tax
Consequences to Non-U.S. Holders&mdash;Dividend Equivalents Under Section 871(m) of the Code&rdquo; in the accompanying product supplement,
Section 871(m) of the Internal Revenue Code of 1986, as amended, and Treasury regulations promulgated thereunder (&ldquo;Section 871(m)&rdquo;)
generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S. Holders with respect to certain financial
instruments linked to U.S. equities (&ldquo;Underlying Securities&rdquo;) or indices that include Underlying Securities. Section 871(m)
generally applies to instruments that substantially replicate the economic performance of one or more Underlying Securities, as determined
based on tests set forth in the applicable Treasury regulations. However, the regulations, as modified by an Internal Revenue Service
(&ldquo;IRS&rdquo;) notice, exempt financial instruments issued prior to January 1, 2027 that do not have a &ldquo;delta&rdquo; of one.
Based on the terms of the securities and representations provided by us as of the date of this preliminary pricing supplement, our counsel
is of the opinion that the securities should not be treated as transactions that have a &ldquo;delta&rdquo; of one within the meaning
of the regulations with respect to any Underlying Security and, therefore, should not be subject to withholding tax under Section 871(m).
However, the final determination regarding the treatment of the securities under Section 871(m) will be made as of the pricing date for
the securities, and it is possible that the securities will be subject to withholding under Section 871(m) based on the circumstances
as of that date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">A determination that the securities are not subject to Section 871(m)
is not binding on the IRS, and the IRS may disagree with this treatment. Moreover, Section 871(m) is complex and its application may depend
on your particular circumstances, including your other transactions. You should consult your tax adviser regarding the potential application
of Section 871(m) to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If withholding tax applies to the securities, we will not be required
to pay any additional amounts with respect to amounts withheld.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should read the section entitled &ldquo;United States Federal
Tax Considerations&rdquo; in the accompanying product supplement. The preceding discussion, when read in combination with that section,
constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding the material U.S. federal tax consequences of owning and disposing
of the securities.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should also consult your tax adviser regarding all aspects of
the U.S. federal tax consequences of an investment in the securities and any tax consequences arising under the laws of any state, local
or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">Supplemental Plan of Distribution</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI, an affiliate of Citigroup Global Markets Holdings Inc. and the
underwriter of the sale of the securities, is acting as principal and will not receive any underwriting fee for any securities sold in
this offering. However, CGMI and its affiliates may profit from expected hedging activity related to this offering. From these expected
hedging profits, CGMI will pay selected dealers participating in the distribution of the securities a structuring fee of up to $5.00 for
each security sold in this offering. We may also engage other firms to provide marketing or promotional services in connection with the
distribution of the securities. CGMI will pay these service providers a fee of up to $5.00 per security in consideration for providing
marketing, education, structuring or referral services with respect to financial advisors or selected dealers.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #2292D0">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #2292D0">PS<FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #2292D0 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">See &ldquo;Plan of Distribution; Conflicts of Interest&rdquo; in the
accompanying product supplement and &ldquo;Plan of Distribution&rdquo; in each of the accompanying prospectus supplement and prospectus
for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">Valuation of the Securities</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI calculated the estimated value of the securities set forth on the
cover page of this pricing supplement based on proprietary pricing models. CGMI&rsquo;s proprietary pricing models generated an estimated
value for the securities by estimating the value of a hypothetical package of financial instruments that would replicate the payout on
the securities, which consists of a fixed-income bond (the &ldquo;bond component&rdquo;) and one or more derivative instruments underlying
the economic terms of the securities (the &ldquo;derivative component&rdquo;). CGMI calculated the estimated value of the bond component
using a discount rate based on our internal funding rate. CGMI calculated the estimated value of the derivative component based on a proprietary
derivative-pricing model, which generated a theoretical price for the instruments that constitute the derivative component based on various
inputs, including the factors described under &ldquo;Summary Risk Factors&mdash;The value of the securities prior to maturity will fluctuate
based on many unpredictable factors&rdquo; in this pricing supplement, but not including our or Citigroup Inc.&rsquo;s creditworthiness.
These inputs may be market-observable or may be based on assumptions made by CGMI in its discretionary judgment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The estimated value of the securities is a function of the terms of
the securities and the inputs to CGMI&rsquo;s proprietary pricing models.&nbsp;&nbsp;As of the date of this preliminary pricing supplement,
it is uncertain what the estimated value of the securities will be on the pricing date because it is uncertain what the values of the
inputs to CGMI&rsquo;s proprietary pricing models will be on the pricing date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For a period of approximately three months following issuance of the
securities, the price, if any, at which CGMI would be willing to buy the securities from investors, and the value that will be indicated
for the securities on any brokerage account statements prepared by CGMI or its affiliates (which value CGMI may also publish through one
or more financial information vendors), will reflect a temporary upward adjustment from the price or value that would otherwise be determined.
This temporary upward adjustment represents a portion of the hedging profit expected to be realized by CGMI or its affiliates over the
term of the securities. The amount of this temporary upward adjustment will decline to zero on a straight-line basis over the three-month
temporary adjustment period. However, CGMI is not obligated to buy the securities from investors at any time.&nbsp;&nbsp;See &ldquo;Summary
Risk Factors&mdash;The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(34,146,208)">Contact</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #2292D0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Clients may contact their local brokerage representative. Third-party
distributors may contact Citi Structured Investment Sales at (212) 723-7005.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&copy; 2026 Citigroup Global Markets Inc. All rights reserved. Citi
and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are used and registered throughout the
world.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #2292D0">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #2292D0">PS<FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $F 8X# 2(  A$! Q$!_\0
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M +[J:B@"'[./^>LO_?='V<?\]9?^^ZFHH A^SC_GK+_WW1]G'_/67_ONIJ*
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M?^/N3_KFO\VJ6HE_X^Y/^N:_S:@"6HKB'[1;2PD@>8A3+*&'(QR#P?H:EHH
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MYTDC&H29C"OC8\:G PO 7D=<G\(]5T_P[-?:AJ]QK!1;9XY;H(P*(2(_++
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M679>'+S6+M-3\4%9&4[H-.0YA@]V_OM^GUK6,$ES3T7XO^N_YF,JC;Y8:O\
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M 55:10QV@EO1&.<8X]Z .IHH!R <8]J* "BBB@ HHHH **** "BBB@ HHHH
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M?^@?JG_@&]'_  E=K_T#]4_\ WJ>BM+4_P"7\?\ @&?[W^;\%_F0?\)7:_\
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MHH **** "BBB@")@YNHR) (PC;D[L>,'\.?SJ6J\GD_;X-V?.\M]GIC*Y_\
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MX506)PH[#I3JN:E_Q[+_ -=4_P#0A5.M(;&4]PHHHJR HHHH **** "BBB@
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M@@C."#U'4'(Z]JYV3P9=746G&ZUB1I;52C#RU90"'#;"WS D,!N)R0HKL**
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M^/N3_KFO\VH EHHHH **** "BBB@"IJ7_'LO_75/_0A5.KFI?\>R_P#75/\
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ML'#==N>/O<'BM?PU)$^BQB"!X(D=T1&D+K@,0"C$ E#VXZ4 7]UY_P \H/\
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M\\\+1PV^LP3N#<7EXYW,LS>?"-A)$Z;0.HYYP&(P* .\W7G_ #R@_P"_A_\
MB:-UY_SR@_[^'_XFK%% %?=>?\\H/^_A_P#B:QM0\1V^FWL7VF[ME&'C:-'9
M]K93EL*=N,CK_>KH:\SU!+=/%M[J-TK3S0SB.&W:<QW.24PT2A?F7KM&1D%L
MY[ 'HFZ\_P">4'_?P_\ Q-&Z\_YY0?\ ?P__ !-6** *^Z\_YY0?]_#_ /$U
MGZCKL6EC_2I+96! ,:R,S\YQ\H7/8_D:V*X+Q5!!<>)?,O&1H+:!76&ZF,2R
MDAN(BJDYS@GOD+C Z@'8P7,]U;Q7$*P/%*@=&$C<J1D'[M2;KS_GE!_W\/\
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MD/G!Z9'/&,^C,.]6-!LI+#2(HI<B1R96CP L18Y** 3A5S@#)Z5I44 %%%%
M&=K6EMJ]A]G2ZDMG5PZR)SR 1R,C/7/7@@'M57PUI4NF6<OG';)(^#&JA$ 7
MY0P4$X+ !CSWK;JM<7L=M=6<#JQ:ZD:-".@(1GY_!30!9HK&B\4:4\HADN/(
ME+.-D@(P%9UR3T&?+?&3SBHD\8Z(3(9+L0JDOEAI5*[OD5B<$9"@.N20!S0!
MM7$"7-O)!+N\N12C;7*G!XX(((/N.:P?#_A[^Q]5U&7S+J5'6..%YY2Y*@$G
MN<G)QD@'COUJW%XETR:^-JDW R/-(PA8,RE<GOE6YZ<=:2/Q/I+RQQF[57E;
M"<$@C=M!)QA<D@<XY- &Q161_P )+ICZ=?WMM,9TL83-*J*0=NTL,;L9R <'
MI52V\9Z7)#-)<R+;K$ZIN$BRJQ()PK(2"0%)(Z@8)X- '1$9!%<S:^'&L[[3
MHXI9Q':_O9I01MN6 91N7.=^&R6'7'/;%ZV\4:3=?:"ER56!F!9T(5@NW+*>
MC+\Z\CUIT?B;1Y;F.W2]!DD;8HV-@G<4ZXQ]X%0>YX% &M16/JGB?2])2Z\^
M9FEMT+M%&A8DA=VT'&-V.<9SCGIS4=YXIL=/FA@N8[E9I(HI2JPLP4.X09([
M@GIUH W**RX/$>CW-U!:PZA"TUPH>)!GY@02![' )P>>.E5V\4V27L%J\<RM
M)+-$[$#;"8SC+\\!N-OKD4 ;E%8B>*](^SB6>X-N?)$S)(IR@VA\$C(W;2#M
M!SCM2R>*M(0X2>24BX2V81PNVUV. #QV/7TH VJQ[S0%N]1GO?M4L<SQ*D+K
M]Z!ESRI]#GE2,''-07?BJVL]7DL)(&/ER1Q.XE3.7Q@A"VX@;AD@>OI2S>,]
M!BLY+E+X3*@;Y849V;"E^ !TV@D'I[T :NGVAL--M;,R&4P0I%YA&"VT 9_'
M%6:Q(_%FDM 'FN# X0,\;HQ*D[1MX'+ LH(&2":D3Q1HTER+9;T>:7\O!C<?
M-OV=<8^]\N?7CK0!KUDZ[H,6MP(#<W%O-&&\MXI&"\CD,H(##Z\^A%,C\4Z.
MXPUZB,(A*P(. -@?[V,$[2#CKBIAKUC):174#M-%)<K:_*I!5RVW!!P1@]:
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+ %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $[ D$# 2(  A$! Q$!_\0
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M47V=?^>DW_?UJ/LZ_P#/2;_OZU $OVB__P">UO\ ]^3_ /%4?:+_ /Y[6_\
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M47V=?^>DW_?UJ/LZ_P#/2;_OZU $OVB__P">UO\ ]^3_ /%4?:+_ /Y[6_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH\@_\]Y_^^A_A4M% $7D'_GO/_WT/\*/(/\ SWG_ .^A_A4M% $7D'_GO/\
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MNC[0/^>,_P#W[J6B@"+[0/\ GC/_ -^Z/M _YXS_ /?NI:* (OM _P">,_\
MW[H^T#_GC/\ ]^ZEHH B^T#_ )XS_P#?NC[0/^>,_P#W[J6B@"+[0/\ GC/_
M -^Z/M _YXS_ /?NI:* (OM _P">,_\ W[H^T#_GC/\ ]^ZEHH B^T#_ )XS
M_P#?NC[0/^>,_P#W[J6B@"+[0/\ GC/_ -^Z/M _YXS_ /?NI:* (OM _P">
M,_\ W[H^T#_GC/\ ]^ZEHH B^T#_ )XS_P#?NC[0/^>,_P#W[J6B@"+[0/\
MGC/_ -^Z/M _YXS_ /?NI:* (OM _P">,_\ W[H^T#_GC/\ ]^ZEHH B^T#_
M )XS_P#?NC[0/^>,_P#W[J6B@"+[0/\ GC/_ -^Z/M _YXS_ /?NI:* (OM
M_P">,_\ W[H^T#_GC/\ ]^ZEHH B^T#_ )XS_P#?NC[0/^>,_P#W[J6B@"+[
M0/\ GC/_ -^Z/M _YXS_ /?NI:* (OM _P">,_\ W[H^T#_GC/\ ]^ZEHH K
MRWB00O+)%.$12S'RSP!S7GD?C34$U>6\+N]H^Y4MS@*!CY?Q'&:Z/QU?2VVC
MQ6\,P1[J38P[LO?Z#.,TQO UJ^C06C7#I<QY<R@ @LV,C'IQ7I894:=/GJ_:
MT^1Y.+=>K4Y*#MRZ_-[+[CE=-\6:K9W4;37DD\!D#2I)\Q([X)Y'X5V&A>*1
MJ4&H374>R.V;<&C0G$?/+>_%9>L>$'32]-MK&V6:X20K<7"*%)4]SS[_ *5S
M.JV5UH.I75BLL@C<;0_W1+&<&NQPP^)7N63_ ,F<*J8G"/W[N/ZM?H='K'C6
M>'4H9=+F2:S,63')'C+9(/OZ5OR>+=,ATV&^9IGCD;8-D9^\!R.?2N%\.: V
MN3W(8NL4,9.Y,9+_ ,*\U2B6^O6MM&"C>DKB.,\8<_>!/X42PE"34%]G?TU%
M#&XB*<W]K;UTV.KT;4(]:\<3ZB(7"16Y6-0-Q[+G]3^=6?'TN_1;<>7(O^D#
MEEP/NFKGA+P^^CVKS7D2"]D.,@Y*)_=STZ\U7^(*DZ# PZ+<#/\ WR:Y%*#Q
M<5#967YG:X3C@9NI\3NW\VA_@?;!X=#"*0M),[%E3.>@'/X5O7*6U[&$NK)Y
MT!W!9(<@'UJ'08HX?#]@L2A4\A6X]2,D_GFM&N*M-NK*2[L]##TU&A&#[(A^
MT#_GC/\ ]^Z7[0/^>,__ '[J6BL3H(OM _YXS_\ ?NC[0/\ GC/_ -^ZEHH
MB^T#_GC/_P!^Z=:2;]5A^21<12??7'=:?1!_R%(/^N4G\TH U:*** "BBB@
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MMH,2?ZB/_EFW]T>U6/M,?]V7_OTW^% $U%0_:8_[LO\ WZ;_  H^TQ_W9?\
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M/3C%>MUY3XGM=-UO7IY+W4I])NR5AB34X)%B"C(8HP8(<\,.>N<@@XH ]3B
M\E!U&T=1BJ[:;:M'Y1B_=8QY8.%'.<C'0Y[U,9(K>W#R2(L:*,N2 *22[MXK
M<7$D\:PG&)"PVG/3F@!@T^T$L4@@0/$NU".P[?S/YTPV=O:6=R+>)8PZL6QW
MXJ1;ZT=XD6YB+2C=&N\98>HIKW4%S9W!@FCE"*RML8'!Q0!F:?\ \@RS_P"N
M$?\ Z"*L57T__D&6?_7"/_T$58H **** "BBB@ HHIKNL4;R.<(BEF/H!R:
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MB13RO[M2,\=SG-=S7FOBRT-YXHO(;2UU2XWPQ"]6"*V*E>=H1Y2&4XSRO\Z
M.\\^&^TM9M.:&[B8 QM'(-K =U89&1V]ZIK8S+IL%H]LTAB;S5"S%".3@;AU
M8 \^M6-#TB+1K%X(G9A+/).V5"X+MG  X '2M*@#"_LR]<^7(0WFF-WFW\Q[
M#T]^,#/N:EM[2XBM;EIE$)%JL"[&#9V!OFZ=]WZ5L5%<\VLW^XW\J ,*PA?^
MS;3_ $B4?N(^R_W1[58\E_\ GYE_)?\ "H-)GBN=&L9H7#QM F&'?"@?TJS+
M-% N^:5(USC<[!1G\:=G>PKJUQODO_S\R_DO^%'DO_S\R_DO^%2T4AD7DO\
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M]L@^UP?\]/\ QT_X4?:X/^>G_CI_PJ?)]:,GUH @^UP?\]/_ !T_X4?:X/\
MGI_XZ?\ "I\GUHR?6@"#[7!_ST_\=/\ A1]K@_YZ?^.G_"I\GUHR?6@"#[7!
M_P ]/_'3_A1]K@_YZ?\ CI_PJ?)]:,GUH @^UP?\]/\ QT_X5@:IX;TG5KZ:
M[EN9DED0+\J_*I'\6,<FNFR?6C)]:N%2=-W@[,SJ4H55RS5T>/M+?::][I",
M_ESMY9C8'YN>& [$\<UWGAS1K+1(%E9R;Z2,+,W)4<YPO'T_*M.\T6QO]0M[
MZXC9I[?[A#8'!R,^N#6CD^M=F(Q?M(*,=+[^;.#"X'V4W*6MOA\D0?:X/^>G
M_CI_PH^UP?\ /3_QT_X5/D^M&3ZUP'ID'VN#_GI_XZ?\*/M<'_/3_P =/^%3
MY/K1D^M $'VN#_GI_P".G_"J]_<02:==)O\ O0N/NGT/M5_)]:BN2?LD_/\
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M_P#?M: ):*B\N;_GY/\ W[6CRYO^?D_]^UH EHJ+RYO^?D_]^UH\N;_GY/\
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M<?\ /=/^_7_UZ-EQ_P ]T_[]?_7J6B@"+9<?\]T_[]?_ %Z-EQ_SW3_OU_\
M7J6B@"+9<?\ /=/^_7_UZ-EQ_P ]T_[]?_7J6B@"+9<?\]T_[]?_ %Z-EQ_S
MW3_OU_\ 7J6B@"+9<?\ /=/^_7_UZ-EQ_P ]T_[]?_7J6B@"+9<?\]T_[]?_
M %Z-EQ_SW3_OU_\ 7J6B@"+9<?\ /=/^_7_UZ-EQ_P ]T_[]?_7J6B@"+9<?
M\]T_[]?_ %Z-EQ_SW3_OU_\ 7J6B@"+9<?\ /=/^_7_UZ-EQ_P ]T_[]?_7J
M6B@"+9<?\]T_[]?_ %Z-EQ_SW3_OU_\ 7J6B@"+9<?\ /=/^_7_UZ-EQ_P ]
MT_[]?_7J6B@"+9<?\]T_[]?_ %Z-EQ_SW3_OU_\ 7J6B@"+9<?\ /=/^_7_U
MZ-EQ_P ]T_[]?_7J6B@"+9<?\]T_[]?_ %Z-EQ_SW3_OU_\ 7J6B@"+9<?\
M/=/^_7_UZ-EQ_P ]T_[]?_7J6B@"+9<?\]T_[]?_ %Z-EQ_SW3_OU_\ 7J6B
M@"+9<?\ /=/^_7_UZ=:+(-5AWR*W[J3&$QW7WI]$'_(4@_ZY2?S2@#5HHHH
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MR?4T9/J: (/M=O\ \]D_.C[7;_\ /9/SJ?)]31D^IH @^UV__/9/SH^UV_\
MSV3\ZGR?4T9/J: (/M=O_P ]D_.C[7;_ //9/SJ?)]31D^IH @^UV_\ SV3\
MZ/M=O_SV3\ZGR?4T9/J: (/M=O\ \]D_.C[7;_\ /9/SJ?)]31D^IH @^UV_
M_/9/SH^UV_\ SV3\ZGR?4T9/J: (/M=O_P ]D_.C[7;_ //9/SJ?)]31D^IH
M @^UV_\ SV3\Z/M=O_SV3\ZGR?4T9/J: (/M=O\ \]D_.C[7;_\ /9/SJ?)]
M31D^IH @^UV__/9/SH^UV_\ SV3\ZGR?4T9/J: (/M=O_P ]D_.C[7;_ //9
M/SJ?)]31D^IH @^UV_\ SV3\Z/M=O_SV3\ZGR?4T9/J: (/M=O\ \]D_.C[7
M;_\ /9/SJ?)]31D^IH @^UV__/9/SH^UV_\ SV3\ZGR?4T9/J: (/M=O_P ]
MD_.C[7;_ //9/SJ?)]31D^IH @^UV_\ SV3\Z/M=O_SV3\ZGR?4T9/J: (/M
M=O\ \]D_.C[7;_\ /9/SJ?)]31D^IH @^UV__/9/SH^UV_\ SV3\ZGR?4T9/
MJ: (/M=O_P ]D_.C[7;_ //9/SJ?)]31D^IH @^UV_\ SV3\Z/M=O_SV3\ZG
MR?4T9/J: (/M=O\ \]D_.C[7;_\ /9/SJ?)]31D^IH @^UV__/9/SH^UV_\
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M +]?_7HV3_\ /PO_ 'Z_^O0!+146R?\ Y^%_[]?_ %Z-D_\ S\+_ -^O_KT
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M +]?_7HV3_\ /PO_ 'Z_^O0!+146R?\ Y^%_[]?_ %Z-D_\ S\+_ -^O_KT
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M +]?_7HV3_\ /PO_ 'Z_^O0!+146R?\ Y^%_[]?_ %Z-D_\ S\+_ -^O_KT
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M_?Y?\: +-%5O[1L?^?ZU_P"_R_XT?VC8?\_UK_W^7_&@"S15;^T;#_G^M?\
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M.,#Z&ME453E5 ^@K)T5;.6YOKRW> RRN$<03;UV*S;#CHI(8D^];% !1110
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M'S9!R,GICWXQ6U56[T^UOBC3QDO'G8Z.R,N>N&4@\T 4] SY%V)6E-T+EOM
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M4\!T9K>:6!/.=,"7;R P)*@\%@.1GOBKL&BZ?;3)+% 08^8U,C,L?^ZI.%_
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7 **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $[ D$# 2(  A$! Q$!_\0
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MI/\ TP_\>H_TG_IA_P"/5+10!%_I/_3#_P >H_TG_IA_X]4M% $7^D_],/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ ):*BV7'_/=/^_7_P!>C9<?\]T_[]?_ %Z ):*BV7'_ #W3_OU_]>C9<?\
M/=/^_7_UZ ):*BV7'_/=/^_7_P!>C9<?\]T_[]?_ %Z ):*BV7'_ #W3_OU_
M]>C9<?\ /=/^_7_UZ ):*BV7'_/=/^_7_P!>C9<?\]T_[]?_ %Z ):*BV7'_
M #W3_OU_]>C9<?\ /=/^_7_UZ ):*BV7'_/=/^_7_P!>C9<?\]T_[]?_ %Z
M):*BV7'_ #W3_OU_]>C9<?\ /=/^_7_UZ ):*BV7'_/=/^_7_P!>C9<?\]T_
M[]?_ %Z ):*BV7'_ #W3_OU_]>C9<?\ /=/^_7_UZ ):*BV7'_/=/^_7_P!>
MC9<?\]T_[]?_ %Z ):*BV7'_ #W3_OU_]>C9<?\ /=/^_7_UZ ):*BV7'_/=
M/^_7_P!>C9<?\]T_[]?_ %Z ):*BV7'_ #W3_OU_]>C9<?\ /=/^_7_UZ ):
M*BV7'_/=/^_7_P!>C9<?\]T_[]?_ %Z ):*BV7'_ #W3_OU_]>C9<?\ /=/^
M_7_UZ ):*BV7'_/=/^_7_P!>C9<?\]T_[]?_ %Z ):*BV7'_ #W3_OU_]>C9
M<?\ /=/^_7_UZ ):*BV7'_/=/^_7_P!>C9<?\]T_[]?_ %Z ):*BV7'_ #W3
M_OU_]>C9<?\ /=/^_7_UZ ):*BV7'_/=/^_7_P!>C9<?\]T_[]?_ %Z ):*B
MV7'_ #W3_OU_]>C9<?\ /=/^_7_UZ ):*BV7'_/=/^_7_P!>D*SJI9IXPHY)
M,? _6@"GK]^FFZ+<S/)Y;,ACC.W=\Y!P*X;P1<I8ZA>S3;L+9-)@<D@$$X_*
MK'C'63>74&EQW$4EMN1WDC P6/ P<GH#535_^*<UU[:(^<@L?LY<K@D,N"?K
M7LX>C:CR-:SU^2L>!BJ]\0JB>D++YNYAW.H7=YN-Q=3R*QSMDD)&,YKK?AF6
M_MZY7+;/LQ(&>,[EJ/PGX6-REOJL\L1A(;9$R;LD''(/;K7;Z381:=?0P6Z1
M1Q>7(P2--HR2F3U-/&8JGRNC%"P&#JN<:\W_ )F_1117BGT 4444 %%%% !7
M/:1_R![/_KDM=#7/:1_R![/_ *Y+0!<HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P _$_\ WT/\*FHH A\@_P#/Q/\ ]]#_  H\@_\ /Q/_ -]#_"IJ* (?(/\
MS\3_ /?0_P */(/_ #\3_P#?0_PJ:B@"'R#_ ,_$_P#WT/\ "CR#_P _$_\
MWT/\*FHH A\@_P#/Q/\ ]]#_  H\@_\ /Q/_ -]#_"IJ* (?(/\ S\3_ /?0
M_P */(/_ #\3_P#?0_PJ:L_6]431])FO&&6 VQKZN>E5&+DU%;LF<E"+E+9%
MKR#_ ,_$_P#WT/\ "CR#_P _$_\ WT/\*Q_".JW.L:1)+=OOGCE*,P0*,8!'
M2MZG4@Z<W![HFE456"G'9D/D'_GXG_[Z'^%'D'_GXG_[Z'^%345!H0^0?^?B
M?_OH?X4>0?\ GXG_ .^A_A4U% $/D'_GXG_[Z'^%'D'_ )^)_P#OH?X5-10!
M#Y!_Y^)_^^A_A1Y!_P"?B?\ [Z'^%344 0^0?^?B?_OH?X4>0?\ GXG_ .^A
M_A4U% $/D'_GXG_[Z'^%'D'_ )^)_P#OH?X5-10!#Y!_Y^)_^^A_A1Y!_P"?
MB?\ [Z'^%344 0^0?^?B?_OH?X4>0?\ GXG_ .^A_A4U% $/D'_GXG_[Z'^%
M0R2V\,OE2Z@4D"%]C2J#M'?&.G!KG?&6NB"WBL]/O66\,H+B%^57'0X]217#
M327^JW7FR^?<SL1'NVDGT XKT:&!=2//)V1Y6)S%4I\D%=FWXI\1R75S+8VE
MW(UDN V2/G8'J&';I5'^QM0@TVQU&UMKG>P:5I8^=HS\I&.G&:[;PIX<?1[:
M5[U(FNI6Z !MBCL#[UT3(K1F,J-C J1T&*U>,A1_=TE=+KW,8X&I7O5K2LWL
MNQY5IFAZEXCD:[\T2)YH2:1Y/G P.>>O%0/I4L7B(Z*TKQ*]P(\GNN?E8@=>
M*]4L-.M-,MOL]G"(HMQ;:"3R?K4IMK<W(N3!&9P-HDVC=CTS2_M%\SLM.@UE
M2Y(W?O7U\^YY==7%YX6UJ]L].NI$C5@#N .X8X)X]S6QHOC%E5H]7N+IYGD"
MQF-54*I]>!WKH=4\)Z=J]\UY<&9964*?+8 ''MBN0\5Z)>1ZQ>W<=LXL]HD\
MW/RC@#^?:MH5*&)2A->];5[:^IA4I8G"-S@_=OHMU;T/1_(/_/Q/_P!]#_"D
M\@_\_$__ 'T/\*XJQ\<7,M_86[0Q&%PD<Q/RD.3C(8GIT-=V>#7E5J$Z+2GU
M/9H8BG73<.A#Y!_Y^)_^^A_A1Y!_Y^)_^^A_A4U%8G00^0?^?B?_ +Z'^%'D
M'_GXG_[Z'^%344 0^0?^?B?_ +Z'^%'D'_GXG_[Z'^%3$[02> !DY[5RP\?:
M1YY0QW6S./,V#'UQG-:4Z4ZE^17L95*].E;GE:YT?D'_ )^)_P#OH?X4>0?^
M?B?_ +Z'^%<Y?>.M.@M_,LXWN7\PIM;Y,8'7OD5M:+JBZQI<5XJJC-D/&K[M
MAST/\_QJIT*D(\TE9$0Q-*I/DA*[+/D'_GXG_P"^A_A1Y!_Y^)_^^A_A4Q(
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M;PRDO-+&04SU))ZD=A78L!):U))(X7F4):4HMO\ 7L=%=^/]/A9TM[:>9ER
MQPJDCI[XKG[C5KKQCJMC9&V"1++RD3D\'&XD^PSS75VW@O2(;'[-/$;A]VXS
M,=K?08Z#VK=M[:"TB6.WACB10  B@<"CV^'I:THMON_S$\/BJVE:24>R_(\C
MCO;C1M5(AD8I;7#$1EB%8@XYQUZ"M>37_$.NW4O]F^<BB-0\-N?N^I'?DUV3
M^&-+>:]F:#=+=YWL^&V$]UR.#4NBZ%9Z'"Z6N]G?[\CG);'3V[UM/&T6N;EO
M+S_$YZ> Q$7R<]HOL_N.5\)^)[M[^/3+Y_-65FQ-*QWJV.!D]N*[*/5-/F,@
MCOK=C&=KXD'RFN.\5>%)#/;S:/8Y1@5E2+KNSG<<FN;U?1+G1Y8(IT)>2$2G
M;R%/.1GVJG0H8EJ<79OIH)8G$X5.$X\R777KL>N17$,S.L4T<A0X<(P.T^^*
MDKS#P==?V?KL37#F*"ZC8!F;:K<\$YZ\@BO38Y(YHQ)$ZNC=&4Y!_&O/Q.']
MC/EO='IX3$_6(<UK/L.HI'=8T+NRJB\EF. /QKC]7\;;+@VFCP?:)@Q4NRDC
M(_N@=?K6=*C.J[01I6KTZ*O-_P"9V-%<+:>/7AT[-Y )[SSBI5/D 3'7OWR*
ML:)XY^VWB6E[;8DFE"1M#T /3=D_RK>6"K13=MC".88>32YM6=E5>\OK:QMY
M)KB5%$:%RNX;B!Z#O6#J?C6STZ]NK,02230@A7&"A?'0^WK7/:=X0N]>LVU2
MYNA#-<2%UW)NW ]6Z\<]*=/#:<]9\JT^9-7&-R]G07-+7Y6-23XA6POE2.S=
MK3/S2$X<C'9?K[UT>C:O#K=A]K@1XP'*%'(R"/I6;?>#[&XTB.QLUCMY593Y
MY3<S8ZY/4YJAX"C6 :K 7!DCG"]<9 R,XJZD</.BY4E9HSI3Q,*ZA6::E?[[
M;?([&BCH,GI4<4\,\?F0S1R1_P!]&!'YBO/L>G<DK&\4:JVD:'+-'N$TA\J-
M@<;6(/S?A@U0E\>Z3'<^4L=S(@)#2J@ 'T!.36'K_B2U\0Q6ME!%+&/M2Y,F
M/F7IG]:[Z&$J>TBYQT/.Q&-I>SDJ<US=!_A/PQ)=2PZK>,517+")T.9.,A\^
MF3G\*[+2-(M=%MY(+3S-LC[V+MDD_6K^T* H  7@ 45C6Q,ZS=WIV-\/A*=!
M*RU[A1117,=84444 %4]6@BN=(O(IEW1F%B1[@9'Z@5<ILJ"2&2,]'4J?Q&*
MJ+LTR9+FBT>0:?IGV_1M0ND)\ZT"28]4.=W]#^%;VG^-I;6WT^QBL5,<82*1
MG<EFYP2/3\:W?#?AZ6ST"\L;Z/RI;IF5BC!CLQ@?UKSM;=XQ-,",6TJJ0>I.
M3C_T&OH%*GB93C+5)Z?-6_,^8E&KA(PE'1R6OR=_R/:CP:*Y_P 3^(VT.UA$
M,0>ZG&4W_=4#&21U[UIZ1?-J6D6MXRJKRIN94.0#WKPG2FH*H]F?1QKPE4=)
M/5%VN-\:7FH2WUIHUB'#3+O(C?#.>0%]AQFD\<:XUNL>G6L[QS9#S%<J0N.,
M'WYK+\$A[_Q(]U<-).\,)(E=B=IX R?IG%=V'P[IP^L2Z)V7Y'G8K$JI4^JP
MW;5W^9FS>(]8CTZ?2KB8E1^[8O\ ZQ<'E=WX8KH'\%0GPPK6J^=J3JLBON*@
M@G.W!.!P?TK1UKPFFH:S9W4$4*0!LW2_=+C.<\#DGFNHX'   [ 4ZV+2C%T=
M'N_^"30P,G*:KZI:)^7D>80>"]6^VVL=Q;X@E(\R2-P?+7OGW_.J<DVI:%J-
M[:Z?=7420R-DXQD#@,1T].:];J&\@%U97$!"GS8F3GW&*4<PDW^\2:_X._4<
MLKA%?NI-/_@;=#A=9\7PW_AD6T,DJ7C[%F^7 88^;GT)KHM!\-66FZ<0ZBXD
MN8U\XR ,O3D#V_G7&:?X;O8/$MG97]IOC+AG/6-E R>?PZ5ZB    , < "C%
MRA2BJ=%Z/4,%&=:;JUUJM%^HR**."%(846.)!A448 'L*?117F'L;!1110 4
M444 %5KO3[2^:%KJ!93"V^,MGY6]?TJS133:=T)Q4E9A1112&%%%% !1110
M40?\A2#_ *Y2?S2BB#_D*0?]<I/YI0!JT444 %>8^+YHG\57=O%O3,,7VM&U
MF.T2X4@[1M92<8R"01UKTZO)?%\UI::Y=17.H7L]U#&CNJV=HQ*'<Q;+IG"K
M@>Y( YH ],TG38-+M'C@9V\Z5YW9WW$LYR>?T^@J>:\@@E2.1B&;'120,G R
M1TY]:DBP8D(SC:.HQ6=>Z4UQJ*W4;(K$(K.<[D"L3\OUR0: +EO?6]U(\<+D
MLG)RI&1G&1D<C(/(K&TC_D#V?_7):OV.FR6\F970I'#Y$6PD'9GJ??ITK#\.
MO%>:!;3#SHU4-&=TS?PD@GK[4[.UQ75[&SC/2BO/M?\ %5O>6C6>F_;5F,H'
MF&0C(!_AP><UC'Q1J_D00K>2J8CRX<[G]FYZ5WPR^K.-WIZGF5,THPDXK7S7
MY'K5+@^E>;7OC*>72X([9I8KYCF:16;:O/ 4$GVYK*N)]=L]1E66XO%NXQYC
MXD)*C YXXQTIPR^H_B:0JF:4H_ F_P"OS/7::[I& 7=4!.,L0*\_/C4R:/(H
M22'40 $?S&9&YY.,\''KQ52RM=6\93%9;LK;6^W>9&) 8C&57U/)J5@9J\JK
MY4BY9C!M1HKFD_ZU.AUSQD+69+;1Q'=SGEW +*N.P Z\9^E4/!UC!J^H7NKW
M:"1UE^2-OF56/.>?3M6]IGA'3-,DAGC$SW,8QYID(R3QG Z5K"TB7[ID7/I(
MP_K2E7IP@X45OUZA##5:E15*[6G3H5_[$TS[<+W[##]IWE_,QSN/?ZU?))ZF
MHOLZ?WY?^_K?XT?9T_OR_P#?UO\ &N-R<MV>A&,8_"K$M%1?9T_OR_\ ?UO\
M:/LZ?WY?^_K?XU)1+147V=/[\O\ W];_ !H^SI_?E_[^M_C0!+2, RE6 *D8
M((R"*C^SI_?E_P"_K?XT?9T_OR_]_6_QH XWX@:</L]I?JR)'%^X\L+CJ201
MV[5B^%M<FL]4M(+B]E2P7<OECE03G''U->D36%M<)LF1I5SG:[EAG\37(^/-
M+ABL;>^AC(=9/+=MQ^Z0<<?6O5PV(C."P\UO?4\7%X:5.;Q5-[6=OZ_(S-:U
M^\\27JZ?8+(+-G"[5&3)SPS>@]JZK0/"EMH<OV@RM/=#<N\?*NT]MM,\)Z/#
M::'!,\+Q74REI&W$,03QT[8Q6]]G3^_+_P!_6_QK'$8BR=&EI%?B=&%PW,U7
MK:R>OH<C<?#Z&6Z:2/4&CB=RQ3RAE03T'-1^+='73M'TZYLTP]BP5I%0#([,
MWX@?G79?9T_OR_\ ?UO\:1K6-AAC(P]#(Q'\ZB.,J\T7)W2-)8"CR2C!6;Z_
MB>=6'A;4/$-J^HRS10M<2E][J<L#G) '&,UZ/!$(+>*$<B-%3@8Z#%-%M&!@
M-*!Z"5O\:7[.G]^7_OZW^-17Q$JV^RV1>&PL*"NMWN^Y+7#Z-$\7Q(OQ)&8]
MRRNH88RI(P:[/[.G]^7_ +^M_C7*W$7E_$>U4,^V6U.3O.3PW?KVJL,])Q[Q
M?X$XN.M.7:2_'0W?$,TMOX=U"6%MKK"<'TSP?YUY?%?7DVE1:+;1DQF4R%8P
M2TC'H#[5T_B[7H4CO='2&X\T;093,2IZ-T_2MW0_#FGV-M;W,<3K=/"-\@E;
M/(&0,'I771DL-1YIQU;NON.*O!XO$<M.6B5G]^J_ YRW\"2W&AQSF5HM0?YO
M*D&%4?W3W!ZFJ0\/MI?B/1K.9A/+,RR2HO1<,> ?3 S7I/V=/[\O_?UO\::;
M2(L&/F%AT)D;(_6L5CZNO-L[_C_D;RRRC9<NC5OP_P R<\FBHOLZ?WY?^_K?
MXT?9T_OR_P#?UO\ &O//3):*B^SI_?E_[^M_C1]G3^_+_P!_6_QH EHJ+[.G
M]^7_ +^M_C1]G3^_+_W];_&@"6BHOLZ?WY?^_K?XT?9T_OR_]_6_QH EKEO&
M5C:P^&KB2&WCC;S4=C&@&XYZG'U/6ND^SI_?E_[^M_C2-:QLI5C(RG@@R,0?
MUK2E4=.:EV,:U)58.#ZH\KTNWO/$>HP6<DYE\J)]AE).U<=,_4CK6UX&U"Y@
MU-])GDVQ!7*Q$#B0$9Y_.NO@T2QMKZ:]A21)YE"N1*P! QV_"N'\6V$>@ZS;
M7.FR2022JTG#<JV<$@^^:]:->.);I)636GD^IXLL-/"*-=N[3U\ULC9$4&I?
M$F8NH=;2 <=MX _QKKDBCB!$<:(#R=J@9_*N&\!VDUQ<7U_/YC!P$$QD(9FS
MDCKD]J[;[.G]^7_OZW^-<.+]V:IW^%)'I8'WJ;J-:R;9+147V=/[\O\ W];_
M !H^SI_?E_[^M_C7&=Q+147V=/[\O_?UO\:/LZ?WY?\ OZW^- $N3C':BHOL
MZ?WY?^_K?XT?9T_OR_\ ?UO\: ):*B^SI_?E_P"_K?XT?9T_OR_]_6_QH EH
MJ+[.G]^7_OZW^-'V=/[\O_?UO\: ):*B^SI_?E_[^M_C1]G3^_+_ -_6_P :
M ):*B^SI_?E_[^M_C1]G3^_+_P!_6_QH EHJ+[.G]^7_ +^M_C1]G3^_+_W]
M;_&@"6BHOLZ?WY?^_K?XT?9T_OR_]_6_QH EHJ+[.G]^7_OZW^-'V=/[\O\
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MH^R6_P#SR'YFIJ* (?LEO_SR'YFC[);_ //(?F:FHH A^R6__/(?F:/LEO\
M\\A^9J:B@"'[);_\\A^9H^R6_P#SR'YFIJ* (?LEO_SR'YFC[);_ //(?F:F
MHH A^R6__/(?F:/LEO\ \\A^9J:B@"'[);_\\A^9H^R6_P#SR'YFIJ* (?LE
MO_SR'YFC[);_ //(?F:FHH A^R6__/(?F:/LEO\ \\A^9J:B@"'[);_\\A^9
MH^R6_P#SR'YFIJ* (?LEO_SR'YFC[);_ //(?F:FHH A^R6__/(?F:/LEO\
M\\A^9J:B@"'[);_\\A^9H^R6_P#SR'YFIJ* (?LEO_SR'YFC[);_ //(?F:F
MHH A^R6__/(?F:/LEO\ \\A^9J:B@"'[);_\\A^9H^R6_P#SR'YFIJ* (?LE
MO_SR'YFC[);_ //(?F:FHH A^R6__/(?F:/LEO\ \\A^9J:B@"'[);_\\A^9
MH^R6_P#SR'YFIJ* (?LEO_SR'YFC[);_ //(?F:FHH A^R6__/(?F:/LEO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME_QH_M&P_P"?ZU_[_+_C0!9HJM_:-C_S_6O_ '^7_&C^T;#_ )_K7_O\O^-
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M_+_C0!9HJM_:-C_S_6O_ '^7_&C^T;#_ )_K7_O\O^- %FBJW]HV'_/]:_\
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MV3S;I)K9][^7*T32)RNW_5@#/WL]>-O?-;&H1V<VF2QW<'VBT=<-&L9DW#V
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MNY>6[V78-Y;^8=RM!]FC4$]<C?@ #=C)R*V] CM?(N+F P^9/+NF6";S$5@
M !Z?* <>]96ISZ2MO_9#0SB&29A*K)(AC5MV2AQW;T[$]J -;79&M-/66*6.
M "51(_RABIZA-PQN/&,U5T1WDN=OF;K5X2Z).8FE+;N6'E\;>><\Y-:&L/9P
M:>;N^WB*U83!HU+,I'<  D]Q^-4M+ELKW7;J[AC<2A-BNJN$:,[3D@@ /NR/
M7"B@!MW+*^MFSCOM,C7:K)');EY%?T/S <]1W_G6AOC;23<)<6I/E%A<E/W>
M0/O$9Z>V?QJGJLUM8?:%B@>XN[M?,^SK&[ARNU=QV@XXVC/L*MVNFV?]A1Z>
ML<C69AV!)MV\K_M9YS]>: *.DS23B">>_P!-D\X[6C@MRI9]I. Q;/0$\CH*
M?K,Y@NK:!+O3K>.8,)%N8=[$=B/F QG@Y]>O:H;:YTW5=8M)$EB9[8$QDS;9
MFD =&5T[@ D\]S5W4;BPL+M+NZ68.8S&72)F4KG.&P".O3\: +%D \3K+-;W
M$L;E7:*/8 < X(R><$=^]8UI=R32S2RZKI!6&0JQCMCRF[ Y+\>G<9J[X;6V
M_LOS[=&C,[^;,A+$+(0 P7/\(Q@=JRKFZT>XCATF*.>2"WN!$RK'*'CQAE"$
M+RN=H/.,9]* -;7'%M#;L+I+2$S!974+O((. N01G.">,X!INF&5M1F@:2UE
MM$MXVA:+;ELL^6*CIP /0X.,<BKNHBTBA2]NV*+:-YJR#.5.,'@=<@D8]ZI:
M,L4U]?7HM)K>:0B,AT=%9 6*L P !.XYQ[9H JF60ZG>1B^MGNHG)@M2$V;=
MO SC<'Y.3GOTQ5B66<>%([HSV\=R;>-Y)SMVYP"Q!^[SSCMG':H]3ETRS:XL
MG:))+HK.R32^6I!8*[*W9@,GCOCUJ]):6::%';;9)+2*) GEY=\+C:1C))&
M<^U &?:2O]OL4M[NWN;*8R&1V"+(S!1A2 !D]\C'3FGZBZKK"P2W\-O&T2M%
M$50AGW')<$9Q]W&".0>^*CLKO3]5\1K-&K^9;Q?NI,,N\GA]P( X 7!]S5C5
M;[3M-O=TP;[7=0F-5,;,D@7) ; ('4_F: )M,:XFL)WN1;&X6:95VD,J@.0H
M) ] ,]_7FL:PN+FX$-U_:-K*QEBCD15C554G!#'JW)(0J>XSWK8T2&U.C!(H
MI%BE:1G27=R68EL;N2N2<>V*H/\ 8+F]L=/BM[F6"SDQYZQR?NY(V4JFX#!7
M(.<G'RC- %G7YY+1+<0W%K:K(S*7E0-DXRHV]U]<<_K4FD*XENH))HYXH]AA
M)V%]I'4[0 %/;OP:L:DUG:K%J-VQC%LV!(/X0Y"G/MTS],U6T..S9KR[MVA,
MLTF)5@F\Q %)"8[+E<$CU)H QQ=7<HN;@:E9^?;DCRT6,(GSX;<QY,8 !X^;
M.>^*W=:D-IICS0M#"0RAI' X4D XSP6QT!ZFL:_FT=H8=&:&<0F8JZLDB-$I
M!(V'&<;MH],$]JWM7-HFG237N\0P$2[D4EE*G(( YSF@#.TCSOM<8DN[>YBF
MA>0E5107# ?(H&0 #\V[/+#WJEXCEO([J6&POX?.:',5HL,9D63G:V7X.3CC
M@\<9Z5=TRYL=1UZ6\@B?>(2L<BJZJR'83O!  ;(P.^!4VJR6UA]H=+=Y[R[B
M)6W6-G$I0  L%!P.5&?<4 6XQ&VELRW43D(P^U%%P",@L1TX(_2N=T>>[EU>
M-I]3AFM"FUI$AB5)I"?E XW XR<>W!-=!8Z?9KHBV,<<IM'1E*3[MQ5B<AMW
M/<]:S4GTW4]6LX_/C9[1F"EI]LQE0E=K+_$,;CS[&@"3Q"[0?9A%?V]L'+*\
M+QH3,..A8$#'OQSR14WAX3OI,8U"437JX\X-&BF,D A2%XZ$'\:FU*>QL;F&
M]NEF#JK('CC9AM.,AL CKCKZ5!X:^SR6$MS!$8GGEWS1@L55PJKA<]!@#@<=
M: ,9KB[.K*%UB"2VBF<SS1PQ 11!6)5L\\,%&1GWQ6WKUQ)I]G'<VXMQMDPZ
MR$+O!1@ ,]]VTX] :R;ZXT62W?1TCGDBBG,<J)'('0%2V(R!S\Q48SC!-=%J
M*VHMA<W;%([4^>)!G*8!R>/8D?0F@#,T0R&58Y)HI8WMUF"DQE@Y/S;=@QM!
MXY[U4N+BY?7Y+!I8E16:2-H&B\U?D3:F&'!)\SWP1SBK^E+#<ZM>WWV2>"4@
M1J7CD17CZ[L, -V2<X]!FF:I<6&GR3PGR5GO )MEQ)LC<J54G=V;&/R% #Y[
MF6/PY!?"2S\T"*260$"-EW+O"D^HR!]1571)IYI;:2:2$BYB>26(F,A9 1PF
MWG@'G.>H[YK1^R6$/A^&W02RV<,<?E-'ND?"D%&!&22" <U1T^[L-4\1/<1(
MPDAA(B<!EWAL;BP(QD$* >N,T ,URZFM]1BM ]NEO<B-3ED#QC<=[X8>A7!Y
MZ=*TM*\R2UE6=HI)(Y60'Y2P Z;]O&[UQZU%J=YIVG7\4MR76XN$,*XC9E=0
M"V&P#P.?S]Z/#L=O_91>&*2/SI&>57W8WG&[;NYVYX'; H P;.^O9[HL;B%O
M*:)&G#0^2P) ?(^^>20N,#D=\DZOB:ZFL8(FMW@7>'7RFV!I&XQC=Q@#=^.W
M/&08KA;"::TTB*VGEM[:8(\D<<G[@J59%# 8(^Z""<8ZUK:E)9V1AU&[8Q^2
M?+$@Z .0"#_LY"G\!0!6T3S'2>.=E<(R^6KE&D12H/S[/EYZC';%:RHJG*J!
M]!65H$=J8KFYMS#YL\N9E@F\Q%(&% ]/E ./4FM>@ HHHH **** "BBB@#)\
M22Q)H5S'*UN/-7RU6<C:V>HYXSC.,UE>#%D5K[]\LT/R*K;D)+ MDC;V(VGG
MN2.U=75>&RB@NI[E=[33X#,[$X49PH] ,D_B: .1U^:6YU>:.QOX9IG00VZ+
MYK-;S ,6/R?+G SAB/N\\<5U4BW[:;M M_M97!RQV?R]/:HKG0].N;A;DVXC
MN$8LLT),;AB",Y7&>">M:- ',Z)83VNORFZ57F6W*^;%&%106!VG"+DGJ.N,
M'IGF;4I+R[U0C2U;S[)2DCLZA/G"MM"D'+8 .>,9QGDUT%4KK2;*\F,TL3>8
M5VLT<C(6'HVTC(^M $>AM -"M6@DE:$)]Z8_,,$YSVX.>G'I7(0D3>+%FM+B
MW;S;L/MA:/8RYY)YW$E,<_WE(Z'-=[%%'!"D42*D: *JJ,  =A45S917;P--
MO(A<2*@8A2PY!([X(!'O0!E>*)U2QCB%[#!(T@<Q2%LS(OWEPGS'CT_'BD\+
M_;3:2R3>7]CE??; >8"J$# P_..IYQUZ 8K5O-/L]0CV7=M%,,$#>N2,]<'J
M*6RLHM/MEMX#)Y2\(KN7VCH "><4 <SKFG:A/*9KJ.&6!Y$40VZAI&P<C#&,
MD'C.=PQZBMS6Y!_9YM-DKR7A-O&L3A&R5))W'I@*3WZ=#TK2J"ZM(+V'R;B,
M2)D,,\$$="".0?<4 9.C?:%U:Y349'-\($^4$>68\M@C'?.<Y [8K&\7202Z
MI#BX@5H(]K[&C\T9(R/G/I@@=R.>U=;::?;6.\P1D-)C>[NSLV.F68DG%2SP
MB>!XB\B!AC=&VUA]#VH JV,IM-"MI;^6*,QVZ&9]XV*0HR<],5RNAG4)-5A^
MS7,%P8<_;)AY^)PPRI);Y<X.?ES[8%=E':6\5FEFL*?9T01B,C(V@8 YZ\56
MM=&L;&[>YM(C \G^L6-R$?C RO3CZ4 0ZU:ZA>1I':&V6,?,S2@$YYX *L,?
MK47AJ-;713F)XAYLCL67:&RQ)8+M7 /4# K:HH Y$-<2M'?2?:(M)N[F*<?O
M%:3<64(3W52=O )(!QP,XUO$TD(T.>&9X%\["@3$8;D$XSP6P"1GC.*L1:)I
MT,Z2I;X*-O1"[%$;U5"=H/T%:% '+>#%E$5YNE66+* ,&0Y8 [L;?X3P1GGD
MCM57Q'.T^K/':7L$LIC$$4*F5F@G^9L_N^ <8/S$?=Z]:ZN"RAM[BXN%WM+.
M1O9V)X&< >@&3Q[FJ]WH>G7DRSR6RK<*V]9HB4<-C&<K@YP3UH ?&-0&E*K_
M &=KT* 220A/J>,]/;K6)I&GW%KXB!NT629;=@)84540$KPQ$:Y)QQR<8/'-
M=.HVJ!DG QDTM &!JKW5WJB1:8K?:;)=[NS@(-XP!@@[C@=>,>O)%7-$>%-$
MB97EV*9-YFQN5@[;P<<##9''&!QQ4]UI=G>RB6:-O-V[-\<C1L5]"5(R/8U8
M@@BMH$A@C6.)!M5%& !0!PEE^\\6++:SV[>;=-(5B:/85RV3UW9*E#_O!ATY
MKI?$TVW3! E[%;3RR+L60M^] (+( OS'(R/E]:T;FQANYK>2;>?(?>BAB%W=
MB1WQVI;JQM;Y EU;QS =-ZYQ]#VH QO"WVQH)IG,?]GS,)+55\P%5*KTW\[3
MR>W7I5/Q#I]_<":6X2"2V?\ =^3"@:20=@"8R0Q]<@ ]QUKI+"P@TVV%M;;Q
M"N B,Y8( , #/0<=*LT 9^LSI%IS0LDKO='[/&L3;6+,#T;^' R<^U9^CK<Q
M:P\>HN_VL6P$:J5\LQANO &6!QU Z\=ZVKFU@O(&@N(Q)&<'!]1R"/0CUJ.T
MTZUL6=X(V\Q\!I'=G8@=!N8DX]J .7\8202WUJIN(%:!27 9/-&2N0-QX!4$
M^Y KH-(=[;P]:/>R1(T<"F63<-HP.3D<?TJW>O%'8SO/*T,*QLSR*<%% Y.>
MV!6!X;\4^$]=C.EZ%J=I=B&/F!22=G3.&Y(YY/O0!FZ4U_-K,?V.[M[IXW:2
MXG_?8EB;=L!)^3TQMS]WC KI=9M;^\A6*S-LJYRS2X)S[ JPJNT.A:+J-O.)
M8K.>]D$$:+(56=@"0NW.#CD].*V@020",CK0!B^%X/(TV8&)T9[AV9BNT2$X
MRRKM7 _ <@GG.3E3237"MJ)-Q#H]W-%*Q$BF3JH5@,953A> 2>3P,UV%9ZZ)
MIR3B5;?!#^8$WML#9SN"9V@YYSB@"+Q'+$FA722M;CS4,:K<$!6)[<\9QFLC
MP8DBR7V)EF@^15;<A.X%NFWL5VGGOD=JZRJ\-E##=SW0WM-, &9F)PHSA1Z#
MDG\30!R_B6Y#ZJ$AO()BL8A%MF4M',22K?N^A(_O8Z<$<UT-DNI)HT2SF&2^
M6, L20K''4\9!-)>:)IU]*)9K9?.5@ZS1DHX8=#N7!R*O(NQ%7).!C+')/UH
M Y?3M.NK;Q) UXBRR+$Y5X$55C!Q]XB-<YQP,GUQWJ]J[W5UJ$5OIRO]JM0)
MV<R!8U#!E ((.XG#?3'7UW*J7>F6E[(LLT;>8HVB2.1HVQZ94@X]J *V@LG]
ME9#REA++YWG8RLF\[QQQ@'.,<8KDXR)_%BS6EQ;-YMV'VPM'M901DGG<24_\
M>7'0YKN[>WAM($@@C6.)!A548 IEU917;PF8N5B<2! Q"E@<@D=\$ CW% %#
MQ',$TEH4O8K:XF95B\QF'F$,"4 7YCD CY>>:I>%3>2>?.#%_9DN&MU D!7@
M9(W\X/)[?3O6[<V=M>1A+F".50<@.H.#ZCT-1Z?IUOID'V>T#I /NQLY8(/1
M<G@>U '.:]IVH3NTMU'#+;NZKY-N@:1\'C#&,D'CKD >HKH=6N4MM/?<LCM,
M1"BQ-M9F<[0 >W7KVJ[45Q;0W<#P7$:R1/U5J ,+1X;JVU6*#4&D\Y+5EMPK
M*4,89 V2 "6!V=0!R<=35/QE)!)/:1F>!9(=SL-R"49V\#=P 5#?CM[9KH[3
M3;2RD>2&-O,<!6DDD:1B!VRQ)Q[59D3S(V3<R[@1N4X(^AH S="+P^'K5KJ1
M,I&2SY7&W)P3C@<8S@X'-<U9/?7.M!M/O+>YD$[3/./.VO Q;8I/W,<8^7/W
M>@ZUV5K9P6EFMK$G[E01ACNSGDYSUR2?SJM#HFGVM[]KM8/L\I 5O)8JK 9P
M"HX(Y/:@!-8M[Z[MQ#9FW )R[3<X], JP_,54\,6YM[6[W1LLCW)9WV!5D.U
M1N4;5P.,=.2"><UN44 <=>2374=UJ*FXBTB=AYSJZF3:AV[D!&5'&>N>I R:
MZ#798XM$NQ(UNOF1-&HN#A&8@X!]C2G1-.,_FFWYW^9LWMY>_.=VS.W.><XZ
MUH4 <?X-1TN[L1S"6W"!<EH\YW-C 0]-I7.>A!QFI/$URIU*%$NX)!&FQ[0F
M4L)&(V-B+D'M\WKQBNCCL88[Z6]^=IY%"$LQ(51V [#/-0WNBZ=J#B2XM4:4
M,&$JY1P0<@[A@\8H CT]-5CT**.Y:"2_6-5+,6"L<#);@D'KZUDZ3IUS:^(D
M-XBR2K;N%E@151 2O#$1KDG' R<8/%=/&GEQ*FYFV@#<QR3]33J ,369)[F\
M@L[!6-Y#BYW%PJ*#N4;@0=V?FXQQC.1Q4WA\@V,N7E:<7$GGB7'RR9^8#'&/
M3'KZYJW=Z;:WKH\\;>8@(62.1D8 ]1N4@X]JEMK6"S@6"WC6.-<X4>_)/N?>
M@#@[AA<>*O/L[BV9I;I"!$\>& *<MD[B=H<<=U7'6NH\2S;=+\A+V*VGED7R
MUD+?O0&!9 %^8Y&1\O/-:%W90WRQK/O*1N)-@8@,0<C/J <'\*==65K>H$NK
M>.8#IO7./IZ4 8GA7[8T4TS&/^SIB'M5'F JI4=-_.T\GMUZ5T55;#3X--MA
M;VV]8%P$1G+! !C ST'M5J@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH IZO:R7VBWUI%M\R>WDB3<<#+*0,_G7FND>!?%+1Z5_:*:/;-HND36%I
MY,CR?:'DC" R\+A!C. <Y)KU:B@#QC2OA;KEK+9S7EII=P(-4BO3;F;*A/**
M2*O[L ?,%;&,' YXS6[X$\ ZSX;\3W&H:A>K.A29&F6;)NB\F\,Z[ <@<99F
MQT'%>E44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
@% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
